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Abstract 
This study describes the NMR-directed isolation and structural elucidation of several new and 
semi-synthesised compounds. Carrying on from the previous examinations on the sponge 
Hamigera tarangaensis undertaken at VUW resulted in the isolation of an additional seven 
congeners to the hamigeran family. These included three debrominated analogues (37, 60, 62), an 
alternative methyl ester analogue (63) and a 4-brominated analogue (64). Two structures with 
novel functionality were also isolated, which were found in fractions previously not investigated, 
the nitrile containing hamigeran R (61) and the dimer hamigeran S (65). The isolation of these 
novel compounds led to the proposal of a biosynthesis from a reaction with hamigeran G (40) 
and ammonia, similar to the previous nitrogenous hamigerans biosynthesis with amino acids.  
Semi-synthesis was undertaken to probe the biosynthesis of these and the other nitrogenous 
compounds. The results of this produced four new compounds: two imine intermediates, 
hamigeran G imine (66) and hamigeran B imine (70), a glycine derived hamigeran (68) and the 
hamigeran D epimer (69).   
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Chapter 1: Marine Natural Products  
1.1  Significance of Natural Products 
Primary metabolites are the building blocks of life, coming in the form of amino acids, fatty 
acids, carbohydrates and nucleobases. These are used to build up macromolecules such as 
proteins, phospholipids, polysaccharides and DNA. They are essential in cellular functions 
including nutrient assimilation, energy production, growth and development. Little variation 
occurs for primary metabolites throughout life to the level of phyla and even kingdom.1 
Secondary metabolites, also called natural products, on the other hand tend to be species specific 
and are used by the organism in a variety of ways, including as pheromones, repellents, venoms, 
toxins; with many having unknown roles for the organism.2 It is thought that during the course 
of evolution if an organism produces a new compound/range of compounds which does not 
hinder the organism but instead gives it a competitive advantage, then this trait will be passed 
on.3 Organisms lacking physical defences or a way to evade predators are more likely to have 
evolved such a chemical defence.4 Secondary metabolites cost the organism energy to produce 
and are therefore often present in low quantities in comparison to primary metabolites. Due to 
the low abundance, secondary metabolites often have a high level of potency and are able to act 
on the desired target at a low concentration. Although there is no defining structure for a 
secondary metabolite, there is a tendency for them to have an amphiphilic nature, this allows 
them to be a least partially soluble in both hydrophobic (to pass though cell membranes) and 
hydrophilic (cytoplasm) media.5 Several large classes of natural products are the glycolipids, 
polyketides and terpenoids which are categorised by their biological origins; it is also common to 
have compounds from mixed biological origins.6 
Since natural products can be exceptionally active in biological systems, they have the potential 
to be useful in the treatment of illness and disease. Unsurprisingly, humans have exploited this 
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potential for thousands of years in the form of herbal medicines, but it has been only in the last 
two centuries that we have had the ability to identify these active compounds.7-9 The discovery of 
drugs such as morphine (1) from the poppy flower, and penicillin G (2) from Penicillium fungi 
illustrate the historical importance of natural products to medicine. Anticancer drugs have also 
been the target of natural products applications. Paclitaxel (3), isolated from the Pacific Yew tree 
in the early 1970’s has been found to be a potent antitumor agent and has since been clinically 
used in the treatment of ovarian and breast cancers.10  
   
1     2     3  
 
 Traditionally, plants and other terrestrial organisms formed the basis behind natural product 
discovery. Marine organisms were more difficult to access, with early collections limited to the 
shore and intertidal zones. Only after World War Two did it become viable to collect in the 
marine environment following the invention of SCUBA by Jacques Cousteau.11 Consequently, 
marine exploration bloomed in the latter third of the 20th century with scientists all over the 
world discovering new organisms and new compounds from their coastlines.12 With the ocean 
covering 70% of the Earth’s surface, there is still plenty more left to be discovered both in terms 
of new organisms as well as new natural products.  
The most studied groups of marine organisms are sponges, corals, molluscs and algae, with these 
contributing significantly to the over 25,000 marine natural products that have been reported in 
the literature.13 However, while many of these have been used in clinical trials, only a few have 
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been developed into drugs. Eribulin (4), marketed under the name Halaven® is an approved drug 
for late stage cancer. This compound is a synthetic analogue of halichondrin B which was 
isolated from the sponge Halichondria okadai, collected around the Pacific coast of Japan.14  
Ziconotide (5), is an ω-conotoxin from the cone snail Conus magus licensed as a pharmaceutical 
for use in the treatment of chronic pain.15  
The first report of marine natural products came from the sponge Tectitethya crypta in 1950, with the 
isolation of the compounds spongothymidine (6) and spongouridine (7), non-ribonucleosides 
containing the arabinose sugar. These compounds provided the inspiration of vidarabine (8), 
cytarabine (9), antiviral and anticancer agents as well as AZT (10), the first effective HIV drug.16  
 
4 
 
5 
    
             8            9             10 
6 R = H 
7 R = CH3 
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1.2:  Isolation Techniques of Natural Products 
Traditionally, organism screening and selection from terrestrial sources was aided with the 
history of traditional medicines, which gave an indication that potential interesting natural 
products would be present in these organisms.17 As no historic body of knowledge associated 
with marine organisms exists a different approach is undertaken for their collection. Gathering 
of organisms may focus on species that are related to already known producers of 
unique/bioactive molecules. As some organisms are difficult to identify in the field, in part due 
to a lack of distinguishing features, the preferred collection technique is to randomly sample 
organisms over several locations.  
Screening with bioassay or structure guided techniques is often undertaken before a 
comprehensive isolation attempt is carried out to give an indication of the organism’s potential. 
The choice of screening protocol often extends into the isolation process and guides the 
purification of compounds.  
1.2.1  Bioassay guided screening and isolation 
The most commonly used method of screening and tracking the isolation of natural products is 
though testing the crude or partially fractionated extracts by bioassay. Crude fractions that show 
a strong response for a chosen assay are elected for further purification. As the fractions go 
through these steps of purification, a particular high activity can be tracked, focusing on these 
fractions, the process repeated until pure compounds are isolated. This technique does have its 
drawbacks. Biological testing takes time, with each fraction generated requiring testing. Small 
amounts of highly active compounds can provide false leads when appearing in fractions with 
larger amounts of mildly active compounds, which may result in the sudden drop off in activity 
during fractionation. Differentiation between known and unknown compounds can also be a 
problem and many steps of purification may be undertaken before it is realised that the active 
compound is one with known biological activity.  
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1.2.2  Structure guided screening and isolation 
An alternative to the bioassay guided approach is structure guided screening and isolation, a 
technique utilised here at VUW by the Marine Natural Products group. Structure guided isolation 
was a traditional method used by natural product chemists before the culturing of cells and 
bioassays was readily available; it has, however, not lost its relevance.18 Due to the advances in 
spectroscopic techniques like high-resolution mass spectrometry and 1D and 2D NMR, 
interesting or unusual functionality can be quickly identified from crude extracts and can direct 
whether further purification could lead to the isolation of new compounds. NMR can be used to 
continually track interesting compounds through the subsequent stages of purification. An 
attitude in the VUW marine natural products group is that chemical novelty of a compound may 
also relate to interesting biological activity. Signals that are not typical of primary metabolites are 
considered unusual and are investigated further. Mass spectrometry can quickly determine if 
certain elements are present such as chlorine, bromine or sulfur.  
1H NMR signals that appear outside of the typical 0.50–5.50 ppm range are often associated with 
interesting structural motifs which can include alkenes, (hetero)aromatics, phenols and 
aldehydes. Knowing the functionality of compounds can help in designing better 
chromatography processes for purification of compounds. This approach is somewhat faster 
than traditional bioassay guided isolation. With the ability to determine known compounds early 
on in the isolation process efforts can be focused on the unknown compounds. It also allows 
selective exclusion of entire classes of compounds that are well known or not relevant to focus 
efforts elsewhere (dereplication).18  
As the biological testing is only performed on pure compounds at the end of isolation process, 
there is the possibility that these compounds will not exhibit the selected bioactivity. This said, 
both structure guided isolation and bioassay guided isolation are powerful tools and not mutually 
exclusive in isolation and discovery of new natural products. 
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1.3  Marine sponges 
Sponges are considered to be the oldest multicellular animals, with fossil evidence dating back to 
the pre-Cambrian era.19 They are considered to be very primitive organisms as they lack many 
characteristics that are common to conventional animals such as developed nervous systems and 
a digestive tract. Classification of sponges can be very difficult as shape, size and colour can 
change depending on the location of the sponge, and often requiring taxonomic reclassification. 
The traditional means of classification to identify sponges is based on the shape of their skeletal 
structure (spicules) and its chemical composition (such as calcium carbonate or siliceous 
spicules). With advances in technology it is now possible to identify the sponge with DNA 
sequencing.20  
The immobile nature of sponges and their lack of physical defences make them prone to 
predation and encroachment. To counter this, sponges often rely on chemical defences of 
secondary metabolites to ward off predators. As such, sponges have been a rich source of novel 
compounds for natural product chemists. Natural products have also been isolated from bacteria 
found in sponges, which often coexist in a symbiotic relationship. The bacteria provides natural 
products and nutrients for the sponge while gaining a host to live within.19  
1.4  New Zealand Marine Natural Products 
New Zealand has a unique marine environment due to its geographical isolation and extensive 
coastline. New Zealand islands and waters span 30 degrees in latitude, ranging from subtropical 
to sub-Antarctic environments (Figure 1.1). Around 80% of New Zealand’s biodiversity is 
thought to be derived from the marine environment, which to date includes almost 800 
identified sponges.21 
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Figure 1.1. New Zealand Exclusive Economic Zone. Image courtesy of NIWA. 
As stated before, marine natural product chemistry is relativity new in terms of chemistry, 
somewhat more so here in New Zealand. Three of the first and most prominent marine natural 
product chemists in New Zealand were Professors John Blunt, Murray Munro (both University 
of Canterbury) and Richard Cambie (University of Auckland). Blunt and Munro started marine 
natural product isolation with red algae, proceeding to sponge-based research later in their 
careers.22,23 Some of their more prominent examples are as follows. 
Discorhabdins B (11) and C (12) are two of several cytotoxic pigments that have been isolated 
from Latrunuclia sp. in New Zealand.24 This genus of sponge is known for its cytotoxic pigments, 
with many other species around the Pacific containing this class of compounds. New Zealand 
sponges also produce halichondrins, the compounds used in the development of Halaven®(4).25 
The novel compound isohomohalichondrin B (13) was isolated from a Lissodendoryx sp. collected 
during dredging off the Kaikoura Peninsula. At the time of isolation of 13, the importance of 
halichondrin B was realised with it already being developed as an anticancer drug. The isolation 
of isohomohalichondrin B was useful in understanding the structure-activity relationship of these 
compounds and was central to the development of Halaven® (4). From the McMurdo Sound 
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(New Zealand’s territory of Antarctica), a collection of the sponge Kirkpatrickia varialosa yielded 
several related alkaloid compounds called the variolins.26 These compounds, such as variolin A 
(14) and D (16) were active against P-388 murine leukaemia cell lines, with variolin B also 
exhibiting antiviral activity.  
    
11     12 
 
13 
  
       14    15 
Of all the species of sponges studied in New Zealand, potentially the most interesting and 
valuable, is Mycale hentscheli. Several isolation studies have been performed from different 
collections around the South Island initially by both professors Blunt and Munro and later by 
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Associate Professors Lyndon West and Peter Northcote. Mycalamide A (16) was first reported in 
1988 from a sample collected from Otago Harbour using a bioassay directed isolation.27 Since 
then, mycalamides B, C, D and E have been isolated from subsequent collections.28-30 A 
collection of Mycale from Fiordland interestingly contained no mycalamide compounds and 
instead yielded the novel compound pateamine (17), a thiazole-containing macrolide.31 Pateamine 
exhibited immunosuppressive activity as well as potent cytotoxicity in the P-388 leukaemia cell 
line (IC50 0.15 ng/ml). In another study, performed at VUW with Mycale from Pelorus Sound in 
the Marlborough Sounds, a new cytotoxic compound, peloruside A (18) was identified.32. The 
cytotoxicity of peloruside A is also on the nanomolar scale with a mode of action similar to the 
anticancer drug paclitaxel (3). Research on its potential use as a cancer treatment drug is  
ongoing. 33-36 
  
16     17 
 
18 
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Chapter 2: The Hamigerans 
2.1  Hamigera sp. 
The genus Hamigera currently has five accepted species, one found in the Mediterranean Sea, two 
from the coast of Australia and Papua New Guinea and two endemic to New Zealand.  Besides 
from the species Hamigera tarangaensis, only a handful of novel compounds have been reported 
from sponges in this genus. The species Hamigera hamigera, native to the Mediterranean, has 
yielded tyrosine and tryptophan amino acid derivatives (19–21), a sulfur containing nucleoside 
(22) and two dimeric steroids (23, 24).37,38 Two sesterterpenoid spiroketals (25, 26) have been 
isolated from Hamigera sp. collected in Papua New Guinea.39 
    
19     20 
 
     
21     22 
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       23     24 
   
25     26 
2.2  Hamigera tarangaensis  
The source sponge of this study, Hamigera tarangaensis (Bergquist and Fromont, 1988) is bright 
yellow in colour (Figure 2.1). Native to the north-eastern waters of New Zealand coasts, the 
sponge is named after Taranga Island, the Maori name for the largest island of the Hen and 
Chicken Islands, from where it was first discovered.40 It has been a rich source of novel 
compounds in the last 20 years. 
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Figure 2.1. Hamigera tarangaensis, photographed by Peter Northcote. 
Cambie’s group were the first to investigate Hamigera tarangaensis. The first paper, published in 
1995, detailed the isolation of a brominated benzocyclooctane compound (27).40 A second paper 
in 2000 revealed the isolation of several 6,6,5- and 6,7,5-tricarbocyclic structures, which Cambie 
dubbed the hamigerans (28–36).41 During the course of his second investigation it was realised 
that compound 27 was incorrectly identified and consequently was reassigned to the structure 35. 
Hamigerans A (28) and B (30) were isolated in the most abundance followed by 
debromohamigeran A (29) and 4-bromohamigeran B (31). Hamigerans C (32) and D (33) both 
contain a seven–membered middle (B) ring, with hamigeran D the only congener containing 
nitrogen. Under mildly acidic conditions (CDCl3) hamigeran D underwent oxidation to 
compound 34. Hamigeran E (35) and debromohamigeran E (36) are oxidised ring-opened 
versions of hamigeran B (30) and 2-debromohamigeran B respectively. The hamigerans were all 
found to have moderate (micromolar) cytotoxicity against the P-388 murine leukaemia cell line. 
Hamigeran B (30) was reported to exhibit a very strong antiviral response against herpes and 
polio viruses.  
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2.3  Synthetic studies 
The somewhat unusual structure of the hamigerans combined with their activity caught the 
attention of synthetic chemists with at least half a dozen syntheses now reported in the  
literature.42-47 Of these, the most extensive work came from the Nicolaou Laboratory with their 
total synthesis of hamigeran B and others using a Diels-Alder trapping method.42 Their work 
involved several attempts that led to non-natural analogues, with the trans-fusion of the B and C 
ring instead of natural cis-fusion, and the isopropyl tail sitting above the ring, before arriving at 
the right configuration. Debromohamigeran A (29) was the first to be fully synthesised with 
simple bromination and decarboxylation reactions able to produce hamigeran A (28), hamigeran 
B (30) and 4-bromohamigeran B (31). This extensive work also led to a new hamigeran analogue, 
28 R= Br 
29 R= H 
30 R= H 
31 R= Br 
35 R= Br 
36 R= H 
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debromohamigeran B (37) which was reacted with H2O2 causing an oxidative cleavage of the  
α-diketone reaction to produce the naturally occurring debromohamigeran E (36).42 
 
37     36 
2.4  VUW Research 
In 2003, the VUW Marine Natural Products group led by Northcote carried out a series of 
sponge collection dives around Northland, New Zealand. As part of his PhD research, Dr 
Jonathan Singh screened a selection of sponge samples from this collection using 1D and 2D-
NMR experiments. One of these, later identified as Hamigera tarangaensis, led to the isolation of 
several new hamigerans (38–44) along with many known variants.48 Some of these new 
compounds were very similar to Cambie’s original hamigeran compounds. For example 
hamigeran G (40) contains a diketone like hamigeran B (30) but with a seven carbon B ring. 
Hamigeran G (40) also was isolated with a minor conformer and in enol form (41) which would 
readily interconvert during purification. With the addition of hamigerans F (38), H (42) and J 
(44), which had different carbon skeletons to the original hamigerans, Singh was able to propose 
a possible biogenesis for these compounds. This started with a diterpenoid origin which goes on 
to form either the hamigerane (six carbon B ring) or isohamigerane (seven carbon B ring) carbon 
skeleton, which then undergoes further derivation to form the observed hamigerans (Scheme 
2.1).  Hamigeran F (38) when left in CDCl3 rearranged to compound 39. This rearrangement, 
along with the degradation of hamigeran D (33) to 34 are the only hamigerans noted to undergo 
a rearrangement so far. Compound 45, a 13-epi-verrucosane congener, was isolated during 
separation but is unrelated to the hamigerans. 
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Scheme 2.1. Biogenesis of the hamigerans proposed by Singh.48 
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2.5  Nitrogenous Hamigerans 
After Singh’s initial isolation of hamigerans 38–44, a visiting academic, Dr Jon Dattelbaum, 
worked on previously un-investigated fractions of the sponge. Several new hamigeran 
compounds were isolated (46–59).48,49 Hamigeran K (46), a partially reduced form of hamigeran 
B (30), was also isolated with a 4-bromo equivalent (47) and C-10 epimer (48). Hamigeran L (49), 
a ring-opened version of hamigeran G (40), and its 11-O-methyl ester (50) were also isolated 
during this time. Dattelbaum and Singh isolated several new nitrogen-containing hamigerans, 
which appear to be derived from amino acid residues. Compounds derived from alanine 
(hamigeran D, 33), phenylalanine (hamigeran N, 52) valine (hamigeran O, 54), leucine 
(hamigeran P, 55) and isoleucine (hamigeran Q, 57) residues have been identified. The re-
isolation of hamigeran D (33) by Dattelbaum led to the reassignment of the configuration for C-
18, finding the original data had been misinterpreted. The C-18 epimers of hamigerans N, P and 
Q, (53, 56, 59) have also been isolated, along with the C-19 epimer of hamigeran Q, (58) 
respectively. A possible biosynthesis has been proposed by Singh (path A of Scheme 2.2) that 
suggests they are produced from a reaction of hamigeran G (40) with an amino acid via 
decarboxylation. The oxazole containing compound hamigeran M (51) appears to be the only 
nitrogenous hamigeran that does not seem to be from a reaction with hamigeran G (40). It has 
been proposed that it is a glycine hamigeran derivative that has undergone an alternative reaction 
(path B of Scheme 2.2).50  
The isolation of three isoleucine-based compounds, hamigeran Q (57) and the two epimers (58) 
and (59) requires at least one must be derived from allo-isoleucine (D- or L-), a nonribosomal 
amino acid typical of prokaryotic secondary metabolism. However the hamigerans core is from 
terpene biosynthesis which is typical of eukaryotes such as sponges. This suggests a possible 
mixed-organism biogenesis for the nitrogenous hamigerans.50 
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49 R = H 
50 R = CH3 
52  
53 18-epi 
55 
56 18-epi 
57  
58 19-epi 
59 18-epi 
46 R = R'' = H, R' = OH 
47 R = H, R' = OH, R'' = Br 
48 R = OH, R' = R'' = H 
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Scheme 2.2. Proposed formation of nitrogenous hamigerans by Singh.49 
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2.6  Isolation of Hamigerans 
When Singh first examined this sponge its identity was unknown. The extract was unusually rich 
for a New Zealand sponge containing approximately ten times the mass of secondary 
metabolites for what is typical. HSQC screening revealed many unusual signals including those 
of highly substituted aromatic rings, deshielded methyl singlets and highly shielded methyl 
doublets. Digestion of the sponge material with HNO3 yielded unusually large microscleres 
(isochelas) siliceous spicules that quickly led to the sponge’s identification as Hamigera tarangaensis. 
Literature revealed the earlier isolation attempts of the hamigeran compounds by Cambie, where 
he utilized the techniques of solvent partitioning and normal phase (silica gel) chromatography in 
extraction of the major constituents of the sponge. From the HSQC screen it was evident that 
some of the signals present in the VUW sample did not match the known hamigerans indicating 
that it was still worth pursuing. Normal phase (silica gel and DIOL) proved to be unusable due 
to loss of compounds and poor separation. A combination of reverse phase chromatography 
with PSDVB (polystyrene-divenyl benzene) resins and HPLC with an acidic buffer resulted in 
the isolation of several new hamigerans. This was further improved with the addition of size 
exclusion chromatography (LH20) with Dattlebaums work, the overall result adding 21 new 
compounds to the hamigeran family. However despite this impressive effort, only a fraction of 
this incredibly rich sponge has been investigated providing the opportunity for further research. 
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2.7  Proposed Research  
The aim of this body of work was to continue work started by Singh and Dattelbaum. The  
Hamigera tarangaensis samples were collected in 2003 from three sites in Northland (Cape Karikari, 
Matai Bay Pinnacle and Taheke Reef). All three had been extracted by Singh in methanol, and 
partitioned on PSDVB as 0%, 20%, 40%, 60%, 80%, 100% Me2CO/H2O fractions. Of these 
only the 80% Me2CO/H2O from Cape Karikari had been extensively examined in both Singh’s 
and Dattelbaum’s research. 1H NMR analysis showed that the 60%, 80% and 100% 
Me2CO/H2O fractions from each site all contained signals indicative of hamigerans. This left 
eight possible fractions from the three sponges meriting investigation. Initially the 100% Me2CO 
fractions were considered not worth perusing due to the high primary metabolite: low hamigeran 
content, but with purification by size exclusion these fractions became easier to work with and 
hamigeran rich and therefore worth investigating.  
The objectives of this research therefore became two-fold. First, to discover new hamigerans 
that complete the functionality series of the already discovered hamigerans, secondly, to discover 
hamigerans with new functionality. As shown by Tables 2.1 and 2.2, there are many missing 
debrominated and 4-brominated congeners which could be yet to be discovered hamigerans.  
The compounds with the hamigerane skeleton such as hamigeran A (28) and B (30), are the most 
abundant hamigerans; it is therefore not surprising that large amounts of debromohamigeran A 
(29) and 4-bromohamigeran B (31) have also been found. Less of the other hamigerans have 
been isolated which leaves the possibility that other debromohamigeran and 4-bromohamigeran 
compounds have not been discovered due to the smaller quantities in the sponge. This logic can 
also be applied to the isohamigeranes which besides hamigeran G (40), are usually found in low 
abundance. In the case of hamigeran H (42), it is reasonable to assume a brominated equivalent 
should be biosynthetically produced. As for hamigeran L (49), which has also been isolated as an 
11-O-methyl ester (50), there is the possibility that the 12-O-methyl ester or dimethyl ester 
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compounds are possible to isolate. With the nitrogen containing hamigerans (Table 2.2) it is 
highly likely that the C-18 epimers of hamigeran D (33) and O (54) are present in the sponge. 
There is also the possibility that oxazole containing compound hamigeran M (51), is just one of 
many compounds with that heteroaromatic core, but substituted analogues would be difficult to 
detect due to the absence of the distinctive oxazole proton resonance. With size-exclusion 
chromatography able to remove most of the remaining primary metabolites from the 60%, 80% 
and 100% Me2CO/H2O fractions, the remaining mass would be hamigeran enriched, allowing a 
more productive throughput on HPLC, greatly increased the mass of fractions that were too 
small in quantity to previously pursue and therefore improving the chances of isolation of new 
congeners.   
It would be safe to assume that there are hamigerans with functionalities that have yet to be 
isolated. This is especially so for compounds with the isohamigerane structure, the larger seven 
carbon B ring giving many more possible combinations of functionality and site of attachment. 
Isolation of hamigerans with these new structures was thought to be more likely in the 60% and 
100% Me2CO/H2O fractions. These fractions would be thought to have a different range of 
compounds than the 80% Me2CO/H2O fraction, with the 60% Me2CO/H2O fraction containing 
more polar hamigerans and 100% Me2CO fraction would more likely to have less polar 
analogues. 
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Table 2.1. Isolated hamigerans from previous research. 
 
 
 
 
 
 
 
 
 
 
 
Table 2.2. Isolated nitrogen containing hamigerans from previous research. 
 
oxazole amino hamigerans Amino acid hamigerans 18-epi-amino acid hamigerans 
hamigeran M (51)   
 hamigeran D (33)  
 hamigeran N (52) 18-epi-hamigeran N (53) 
 hamigeran O (54)  
 hamigeran P (55) 18-epi-hamigeran P (56) 
 hamigeran Q (57) 18-epi-hamigeran Q (58) 
 19-epi-hamigeran Q (59)  
 
 
 Debromination hamigerans 4-Brominated 
ha
m
ig
er
an
e 
debromohamigeran A (29) hamigeran A (28)  
 hamigeran J (44)  
debromohamigeran E (36) hamigeran E (35)  
 hamigeran B (30) 4-bromohamigeran B (31) 
 hamigeran K (46) 4-bromohamigeran K (47) 
 10 epi-hamigeran K (48)  
is
oh
am
ig
er
an
e 
hamigeran H (42)   
 hamigeran F (38)  
 hamigeran C (32)  
 hamigeran I (43)  
 hamigeran G (40)  
 hamigeran L (49)  
 hamigeran L 11-O-methyl ester (50)  
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Chapter 3: New Hamigerans from Hamigera tarangaensis 
 
The two least worked on sponge samples were used for this research, the specimen from Matai 
Bay Pinnacle and the other from Taheke Reef. The 80% Me2CO/H2O fraction from Matai Bay 
Pinnacle had a high mass and revealed several signals in the 1H NMR common to previously 
isolated hamigerans with traces of unidentified compounds. The 100% Me2CO fraction from 
Matai Bay Pinnacle and 60% Me2CO/H2O fraction from Taheke Reef were also targeted due to 
the presence of several previously unobserved hamigeran-like signals in both samples. The 60% 
Me2CO/H2O fraction (m) was subjected to size exclusion chromatography generating 95 
fractions that were pooled into four groups; Fats, A, B and C the latter of which was separated 
with reversed-phase C18 HPLC generating nine fractions. Two of these fractions were pure, one 
containing debromohamigeran I (60) and the other hamigeran R (61) (Scheme 3.1). 
 
Scheme 3.1. Isolation of debromohamigeran I and the novel compound hamigeran R.  
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 The Matai Bay Pinnacle 80% Me2CO/H2O fraction (i) was subjected to size exclusion 
chromatography treatment though a series of columns generating around 70 fractions per 
column. These were pooled into four fractions as Fats, A, B and C. The largest fraction, B, was 
separated into 16 fractions using reversed-phase C18 HPLC (MeOH/H2O 0.2 M HCOOH), 
many of which contained pure compounds including debromohamigeran A (29), hamigeran A 
(28), hamigeran B (30), 4-bromohamigeran B (31) and hamigeran G (40). Some of the fractions 
that looked promising by 1H NMR and had significant mass were further purified using C18 
HPLC. Fraction E was separated into an additional seven fractions, containing hamigeran F (38) 
and a new compound, debromohamigeran J (62). Fraction F was separated using a gradient of 
60%–100% MeCN/0.2 M HCOOH(aq) resulting in 12 fractions with two new compounds, 
hamigeran L 12-O-methyl ester (63) and debromohamigeran B (37). The new hamigeran 4-
bromohamigeran A (64) was isolated after two additional HPLC separations of fraction N 
(Scheme 3.2).  
The 100% Me2CO (j) fraction of the Matai Bay Pinnacle specimen was the last to be investigated. 
Pooled as five fractions after separation with size exclusion chromatography, Fats, AR, AS, AT 
and AU. Lipids and steroids were still in these fractions despite the majority being removed by 
LH20. Further investigation of the fraction AS led to the isolation of the new compound 
hamigeran S (65) after two HPLC separations (scheme 3.2). The HPLC running conditions 
required for the purification of hamigeran S (65) were much less polar compared to the isolation 
of the other hamigerans, not requiring the use of a buffer. 
26 
 
Scheme 3.2. Isolation of several new and novel hamigerans. 
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3.1 Debromohamigeran B (37) 
 
Debromohamigeran B (37) was isolated as a bright yellow film. The molecular formula of 
C18H22O3 (∆ = +1.08 ppm) was established from positive-ion mode HRESIMS analysis of the 
[M+H]+ adduct ion m/z 287.1645. Analysis of the 13C and 1H NMR spectra coupled with HSQC 
data provided evidence of 18 distinct carbon resonances coupling to 21 of the 22 protons of the 
molecular formula, indicating the presence of an exchangeable proton, 1-OH (δH 11.93). The 
HSQC established the presence of four methyls [CH3-15 (δC 24.5, δH 1.30); CH3-14 (δC 23.2, δH 
0.42); CH3-16 (δC 22.6, δH 2.39); CH3-13 (δC 19.8, δH 0.54)] two methylenes [CH2-8 (δC 33.2, δH 
2.62, 1.56); CH2-7 (δC 26.9, δH 1.79, 1.68)] and three alkyl methines  
[CH-5 (δC 56.5, δH 3.4); CH-6 (δC 51.4, δH 2.29); CH-12 (δC 28.1, δH 1.2)]. The remaining carbons 
were identified as two carbonyls [C-10 (δC 200.1); C-11 (δC 184.3)], six olefinic sp
2 carbons [C-1 
(δC 164.6); C-3 (δC 150.8); C-4a (δC 144.2); CH-4 (δC 123.4, δH 6.69); C-11a (δC 116.7); CH-2 (δC 
116.2, δH 6.73)] and one quaternary sp
3 carbon [C-9 (δC 56.9)]. The molecular formula required 
eight degrees of unsaturation, five of which could be explained as the two double bonds from 
the carbonyls and three from the six olefinic carbons, with the remaining three hydrogen 
deficiencies indicating that the structure is tricyclic.   
On the basis of extensive 2D NMR data analysis three substructures could be assembled. The 
first was determined to be a tetra-substituted aromatic ring, accounting for all six of the olefinic 
carbons. It was assembled on the basis of HMBC correlations from three of the substituents as 
seen in Figure 4.1. The protons of the olefinic methyl CH3-16 showed HMBC correlations to the 
aromatic methine carbons, CH-2 and CH-4, along with a correlation to the non-protonated 
carbon C-3 that established the C-2 to C3 and C-3 to C-4 bonds along with the methyl 
attachment to C-3. The phenol proton, 1-OH could be established to have a connection to C-1 
though an HMBC correlation, consistent with the downfield shift of C-1 (δC 164.6). Further 
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HMBC correlations from 1-OH established the connection between CH-2 and C-1, as well as 
the connection of C-1 to the carbonyl C-11a. The protons of an alkyl methine, CH-5 showed 
HMBC correlations to the carbons of both CH-4 and C-11a along with a weak correlation to a 
non-protonated carbon C-4a, providing the last position of the aromatic ring. These correlations 
finally established the C-11a to 4a, C-4a to C-4 and C-5 to C-4a bonds clearly identifying an 
aromatic ring (substructure 1, Figure 3.1). A weak correlation observed in the HMBC between 1-
OH and the carbonyl C-11 established the connection of C-11a to C-11 identifying the last 
substituent on the aromatic ring. The assignments for the ring were further confirmed with 1H-
1H couplings observed in the COSY experiment, with meta coupling detected between CH-2 and 
CH-4 and three cases of extended allylic coupling from CH-2 with CH3-16, CH3-16 with CH-4 
and CH-4 with CH-5.  
 
 
 
Figure 3.1. Key HMBC and COSY correlations establishing the aromatic ring  
(substructure 1) of debromohamigeran B (37). 
 
The second substructure (substructure 2, Figure 3.2) identified was a three carbon unit, a linear 
sequence of a methine, CH-6 and two methylenes, CH2-7 and CH2-8 as evidenced from 
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correlations in the COSY spectrum. The final substructure (substructure 3, Figure 3.2) was 
another three carbon sequence, identified as an isopropyl unit, established from COSY 
correlations of a methine, CH-12 to two methyls, CH3-13 and CH3-14.  
 
 
 
Figure 3.2. COSY correlations for the hydrocarbon sequence (substructure 2) and the isopropyl 
unit (substructure 3) spin systems of debromohamigeran B (37). 
With these substructures identified, all the carbons of the molecular formula were accounted for 
except for a quaternary carbon C-9, a methyl singlet CH3-15 and a carbonyl C-10. The absence 
of coupling from the protons of CH3-15 to a non-protonated alkyl carbon C-9 was evident by 
HMBC and consistent with its lack of 1H-1H splitting. The other bonds to C-9 were also 
identified by HMBC correlations from the protons of CH3-15 to the carbons of CH2-8, CH-5 
and the ketone C-10. These connections linked substructure 1 to substructure 2 (Figure 3.3). A 
cyclopentyl (C) ring was also established with the identification of the bond between C-5 and C-6 
from a strong correlation observed with COSY, which again connected the substructures 1 and 2 
together accounting for one of the two remaining degrees of unsaturation. 
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Figure 3.3. HMBC Correlations of CH3-15 connecting substructure 1 and 3 together and 
establishment of the cyclopentyl ring (ring C) of Debromohamigeran B (37). 
Substructures 2 and 3 were connected with the remaining unassigned bond of CH-6 and CH-12 
with correlations seen in the HMBC from the methyl protons of the isopropyl unit to the carbon 
of CH-6 and a correlation from the proton of CH-6 to the carbon of CH-12 (Figure 3.4). With 
all the atoms of the chemical formula now assigned, the remaining degree of unsaturation could 
be assigned to a linkage between the two carbonyls, C-10 and C-11, providing the final ring (ring 
B) of the tricyclic structure, completing the planar structure (Figure 3.5). Additional evidence of 
this bond comes from the chemical shifts of the carbonyls. A ketone carbonyl shift in 13C NMR 
is normally around 220 ppm but moves upfield when adjacent to other sp2 centres. C-10 (δC 
200.1) is vicinal to one sp2 carbon, while C-11 (δC 184.3) is next to two sp
2 carbons.  
 
31 
 
 
Figure 3.4. Key HMBC correlations establishing substructure 3 to substructure 2 and 
connection of the ketones Debromohamigeran B (37). 
 
 
Figure 3.5. Completed planar structure of debromohamigeran B (37). 
The relative configuration of debromohamigeran B (37) was established with NOESY 
correlations from the three stereogenic centres, CH-5, CH-6 and C-9. A NOE correlation 
between the methine CH-5 and methyl CH3-15 established the cis-fusion of the B and C rings 
while NOE correlations from both CH-5 and CH3-15 with the methine proton CH-6 indicated 
they were on the same plane, placing the isopropyl tail below the C ring (Figure 3.6). Further 
evidence of this assignment of configuration comes from the shifts of the isopropyl tail protons 
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being very similar to that of hamigeran B (30), where a change in configuration of the tail would 
significantly alter the chemical shifts of the protons.42 This is consistent with the stereogenic 
relationship of all other known hamigerans. Assuming the same absolute stereochemistry, this 
defines the absolute configuration of debromohamigeran B (37) as 5R, 6R, 9R.  
 
Figure 3.6. Key NOE correlations establishing the relative configuration of  
debromohamigeran B (37). 
 
As is evident by the name, debromohamigeran B (37) is the 2-debromo analogue of hamigeran B 
(33), which was synthesised by Nicolaou.42 The spectral data matches that of the synthetic 
material.42 It has very similar chemical shifts to the previously isolated hamigerans, especially 
hamigeran B (30) and 4-bromohamigeran B (31). As expected the main differences are observed 
in the aromatic ring as summarised in Table 3.1. There is a noticeable downfield shift observed 
for C-2 and C-1 when a bromine is replaced with a proton on C-2 and an equivalent upfield shift 
for C-4 if a bromine is attached to that position. The optical rotation data gave a rotation of the 
same sign and order as the hamigeran B (30) and 4-bromohamigeran B (31).41,48 
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Table 3.1. Chemical shifts of the aromatic carbons from hamigeran B (30) and its derivatives. 
 
Position Hamigeran B (30) 4-Bromohamigeran B (31) Debromohamigeran B (37) 
C-1 160.8 160.1 165.7 
C-2 111.6 113.3 116.2 
C-3 150.2 149.8 150.8 
C-4 124.3 119.3 123.4 
C-4a 142.8 142.1 144.2 
C-11a 117.3 117.6 116.7 
 
The sharp, down-field nature of the phenol 1-OH in the 1H NMR is also consistent with the 
phenol containing hamigerans with a ketone at C-11, with hydrogen bonding occurring between 
the phenol proton and the nearby ketone causing the deshielding effect observed.  
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Table 3.2. NMR data (600 MHz) of debromohamigeran B (37) in CDCl3. 
 
 
 
 
 
13C 
  
1H 
  
HMBC 
 
Position  (ppm) mult. 1JCH (Hz)  (ppm) mult. 3JHH (Hz) COSY (1H → 13C) NOESY 
1 164.6 C 
       
1-OH 
   
11.93 
   
1, 2, 11(w), 3, 11a 
 
2 116.2 CH 160 6.73 
  
4, 16 1, 4, 16 16 
3 150.8 C 
       
4 123.4 CH 163 6.69 
  
2, 16, 5 1(w), 3(w), 4a, 2, 5, 16 16, 5, 13 
4a 144.2 C 
       
5 56.5 CH 130 3.40 d 9.0 4, 6 10, 4a, 4, 11a, 9, 6, 12, 15 6, 15, 7a(w), 8a(w) 
6 51.4 CH 129 2.29 m 
 
5, 7a 5, 8, 12, 7, 13, 14 5, 7a, 13, 14 
7 26.9 CH2 130 a) 1.79 m  
6, 7b 5, 6, 8, 12 5(w), 8a(w), 6, 7a, 8a, 8b, 13(w), 14(w) 
   
130 b) 1.68 m 
 
7a, 8a, 8b(w) 5, 6, 8, 12 8a, 7a, 13(w), 14(w) 
8 33.2 CH2 130 a) 2.62 ddd 5.6, 7.6, 13.3 7b, 8b 10, 9, 6, 7 7a(w), 7b, 8b 
   
130 b) 1.56 m 
 
8a, 7b(w) 10, 9, 6, 7, 15 5(w), 8a, 7a, 15 
9 56.9 C 
       
10 200.1 C 
       
11 184.3 C 
       
11a 116.7 C 
       
12 28.1 CH 119 1.20 m 
 
13, 14 6(w), 5(w), 7(w), 13, 14 13, 14 
13 19.8 CH3 125 0.54 d 6.7 12 14, 12, 6 6, 7a(w) ,7b(w) ,12, 14 
14 23.2 CH3 125 0.42 d 6.4 12 13, 12, 6 6, 7a(w), 7b(w), 12, 13 
15 24.5 CH3 132 1.30 s   
10, 9, 5, 8 5, 8b 
16 22.6 CH3 124 2.39 s   
3, 4, 2 2, 4 
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3.2 Debromohamigeran I (60) 
 
Debromohamigeran I (60) was isolated as a pale yellow film. HRESIMS analysis revealed a 
[M+H]+ adduct ion at m/z 319.1902, establishing a molecular formula of C19H26O4 (Δ = −0.6 
ppm). Analysis of the 13C and 1H NMR spectra coupled with HSQC data indicated that 13 of the 
19 carbons were attached to 23 of the 26 protons. Overall this was broken down as four methyls 
[CH3-16 (δC 30.0, δH 1.24); CH3-14 (δC 23.2, δH 0.18); CH3-15 (δC 22, δH 0.76); CH3-17 (δC 21.8, 
δH 2.32)], two methylenes [CH2-7 (δC 32.3, δH 1.60, 1.90); CH2-8(δC 34.4, δH 1.40, 2.59)], five alkyl 
methines [CH-11 (δC 74.4, δH 4.56); CH-10 (δC 74.1, δH 3.33); CH-5 (δC 61.3, δH 3.46); CH-6 (δC 
53.7, δH 2.21); CH-13 (δC 29.5, δH 1.12) and two oxymethines [CHOH-11 (δC 74.4) and CHOH-
10 (δC 74.1)]. The other carbon signals included a ketone C-12 (δC 204.2), six olefinic sp
2 carbons 
[C-1 (δC 164.8); C-4a (δC 148.5); C-3 (δC 143.0); CH-4 (δC 127.8, δH 6.64); CH-2 (δC 117.9, δH 
6.77); C-12a (δC 115.4)] and one quaternary sp
3 carbon [C-9 (δC 47.7)]. The three exchanagble 
protons were identified as the phenol proton 1-OH (δH 12.54) and the two on the oxymethines. 
The molecular formula requires seven degrees of unsaturation which could be attributed to one 
carbonyl and six olefinic carbons, the remaining three hydrogen deficiencies indicated a tricyclic 
structure.   
The substructures 1, 2 and 3 identified in debromohamigeran B (37) were again present in 
debromohamigeran I (60) and elucidated in a similar fashion (Figure 3.7). HMBC correlations 
from three of the aromatic substituents pieced together substructure 1 with COSY correlations 
confirming their assignment. Substructures 2 and 3 were again assembled using COSY 
correlations.  
36 
 
 
Figure 3.7. Key HMBC and COSY correlations establishing substructures 
 1, 2 and 3 of Debromohamigeran I (60). 
COSY correlations between CH-5 and CH-6 identified the connection between substructures 1 
and 2 (Figure 3.8). COSY and HMBC correlations pieced together substructure 3 to 2 
establishing the bond between C-13 and C-6. With these substructures identified and assembled 
together, all but the quaternary carbon C-9, the methyl singlet CH3-15 and the two oxymethines 
CHOH-10 and CHOH-11 were accounted for. 
 
Figure 3.8. Key HMBC and COSY correlations connecting substructure 1, 2 and 3  
together for debromohamigeran I (60). 
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As for the previous compound, HMBC correlations showed CH3-16 was attached to C-9, with 
further HMBC correlations establishing that carbons CH2-8 and CH-5 connected to C-9, again 
connecting substructure 1 and 2 together forming a cyclopentyl ring (Figure 3.9). The remaining 
bond to C-9 was identified as CHOH-10 though a HMBC correlation from CH3-16. Connection 
of CHOH-10 and CHOH-11 was evident from COSY correlations, HMBC correlations from 
both centres to the ketone C-12 identified the bond between CH-11 and C-12 closing the seven 
membered B ring. This completed the planar structure of debromohamigeran I (60) (Figure 
3.10), the debrominated analogue of hamigeran I (43). 
 
Figure 3.9. Key HMBC correlations for CH3-15 and HMBC and COSY correlations CH-10 and 
CH-11 of debromohamigeran I (60). 
 
Figure 3.10. Completed planar structure of debromohamigeran I (60). 
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Debromohamigeran I (60) includes five stereogenic centres (Figure 3.11). NOE correlations 
between CH-5, CH-6 and CH3-16 confirmed the usual cis-fused ring configuration and the 
isopropyl unit sitting below the ring. CH-5 and CH3-16 both had NOE correlations to CH-10 
indicating the proton was on the same face, placing it above the ring while the hydroxyl sits 
below. A NOE correlation between CH-11 and CH-13 indicated both protons sit below the 
rings. This was evident from the large splitting between H-10 and H-11 in 1H spectrum (3JHH = 
10.9 Hz) indicative of a trans relationship between the two protons. These assignments matched 
previous assignments of the brominated analogue hamigeran I (43) and assuming the same 
absolute stereochemistry, established the absolute configuration of debromohamigeran I (60) as 
5R, 6R, 9R, 10R, 11S. The optical rotation data gave a rotation of the same sign and order as the 
hamigeran I (60).48 
 
Figure 3.11. Key NOE correlations for debromohamigeran I (60). 
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Table 3.3. NMR data (600 MHz) of debromohamigeran I (60) in CDCl3. 
 
 
  13C     1H   
 
HMBC 
 Position  (ppm) mult. 1JCH (Hz)  (ppm) mult. 3JHH (Hz) COSY (1H → 13C) NOESY 
1 164.8 C 
       1-OH 
   
12.54 
   
12(w), 3, 2, 12a 
 2 117.9 CH 163 6.77 
  
4, 17 1, 4a, 3, 12a, 17 17 
3 143.0 C 
       4 127.8 CH 160 6.64 
  
2, 17, 5 12, 3(w), 4, 2, 12a, 5, 17 5, 17, 14(w) 
4a 148.5 C 
       5 61.3 CH 124 3.47 d 11.7 4, 6 4a, 4, 12a, 10, 6, 9, 7(w), 13 4, 6, 16, 10 
6 53.7 CH 127 2.21 m 
 
5, 7b, 13(w) 5(w), 9(w), 7(w), 13(w), 14(w), 15(w) 5, 14, 15 
7 32.3 CH2 127 a) 1.60 m 
 
8b 10(w), 6, 8(w) 11, 8b, 7b 
 
  
127 b) 1.90 m 
 
6, 8a, 8b(w) 5, 6(w), 9 7a, 8a, 15(w) 
8 34.4 CH2 128 a) 1.40 m 
 
7b, 8a 10, 9, 7, 16 8b, 7b 
 
  
128 b) 2.59 ddd 2.9, 7.4, 13.6 7a, 8b, 7b(w) 10, 5, 6, 9, 7(w) 11(w) ,8a, 7a 
9 47.7 C 
       10 74.1 CHOH 148 3.33 d 10.9 11 12, 11, 9, 8, 16 11, 5, 16 
11 74.4 CHOH 146 4.56 d 11.0 10 12, 12a(w), 10, 9 10, 7a, 13, 8b(w) 
12 204.2 C 
       12a 115.4 C 
       13 29.5 CH 127 1.12 m 
 
6(w), 14, 15 6(w), 14(w), 15(w), 5(w) 11, 14, 15 
14 23.2 CH3 120 0.18 d 6.2 13 6, 13, 15 4(w) ,6, 13, 15 
15 22.0 CH3 125 0.76 d 6.5 13 6, 13, 14 6, 7b(w), 13, 14 
16 30.0 CH3 124 1.24 s 
  
10, 5, 9, 8 5, 10 
17 21.8 CH3 128 2.32 s 
 
2, 4 3, 1(w), 4, 2 2, 4 
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3.3 Debromohamigeran J (62) 
 
Debromohamigeran J (62) was isolated as a colourless film. HRESIMS revealed a formula of 
C20H26O5 (Δ = +2.8 ppm) from a [M+NH4]
+ adduct ion of m/z 364.2118. Analysis of 13C and 1H 
NMR spectra coupled with HSQC revealed 12 of the 20 carbons were attached to 24 of the 26 
protons. This included three alkyl methines [CH-5 (δC 57.8, δH 3.42); CH-6 (δC 51.0, δH 2.18); 
CH-12 (δC 27.1, δH 1.29)], two methylenes [CH2-8 (δC 35.1, δH 2.59, 1.45); CH2-7 (δC 26.3, δH 
1.67, 1.70)] and four methyls [CH3-12 (δC 27.1, δH 1.29); CH3-13 (δC 23.2, δH 0.45); CH3-16 (δC 
21.4, δH 2.31); CH3-14 (δC 19.3, δH 0.46)] and a methoxy [CH3-18 (δC 53.6, δH 3.72)]. The 
remaining carbons were assigned as six olefinic sp2 carbons [C-1 (δC 156.0); C-3 (δC 140.4); C-4a 
(δC 136.4); CH-4 (δC 123.6, δH 6.65); C-11a (δC 118.0) CH-2 (δC 116.3, δH 6.68)], two carbonyls 
[C-10 (δC 209.2); C-17 (δC 169.9)] and two quaternary carbons [C-11 (δC 78.1); C-9 (δC 54.7)]. The 
remaining two protons were assigned to hydroxyls with broad singlets observed in the 1H NMR 
spectrum [1-OH (δH 6.86) ; 11-OH (δH 5.09)]. The molecular formula indicated eight degrees of 
saturation which could be accounted for by two carbonyls, six olefinics and a tricyclic structure. 
Like the previous compounds the structure of debromohamigeran J (62) was solved from COSY 
and HMBC correlations. Substructures 1, 2 and 3 were the same as the previous two compounds 
except that in substructure 1, no HMBC correlation was detected from the phenol to C-11 
(Figure 3.12). Instead a weak HMBC correlation from CH-4 was used to assign the position of 
the quaternary carbon C-11 (δC 78.1), explaining the phenolic proton’s more upfield shift 
compared to the previous described hamigerans due to a lack of hydrogen bonding. These 
substructures were assembled together using the same HMBC and COSY correlations as before 
(Figure 3.13), establishing the bonds from CH-5 to CH-6 and CH-6 to CH-12 along with 
cyclopentyl ring identified though HMBC correlations from the isolated methyl CH3-15 to CH-5 
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and CH2-8. The methyls remaining HMBC correlation established a connection to the carbonyl 
C-10. 
 
Figure 3.12. Key HMBC and COSY correlations of substructures 1, 2 and 3 of 
debromohamigeran J (62). 
 
Figure 3.13. Key HMBC and COSY correlations connecting the three substructures and 
forming the cyclopentyl ring of debromohamigeran J (62). 
The remaining atoms still to be assigned were carbonyl C-17, a hydroxyl and methoxy C-18. The 
hydroxyl 11-OH provided a weak HMBC correlation to its attachment point, the quaternary 
carbon C-11, along with weak HMBC correlations to C-10 and C-11a establishing the final ring 
of the tricyclic structure (Figure 3.14). CH3-18 was identified to be part of a methyl ester from a 
HMBC correlation to the carbonyl C-17. The final bond of C-11 was determined to be to the 
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carbonyl C-17 based on both their carbon chemical shifts and in accordance with the molecular  
formula. This completed the planar structure (Figure 3.15) of debromohamigeran J (62), the 
third debrominated analogue of a known hamigeran.    
 
Figure 3.14. Key HMBC correlations from 11-OH and CH3-18 of debromohamigeran J (62). 
 
Figure 3.15. Completed planar structure of debromohamigeran J (62). 
Debromohamigeran J (62) has four stereogenic centres (Figure 3.16). NOE correlations between 
CH-5, CH-6 and CH3-15 established the typical cis-fusion between the B and C rings along with 
the isopropyl tail sitting below the C ring. A NOE correlation between CH3-15 and CH3-18 
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identified that the methyl ester was on the same side as the ring junction methyl CH3-15, 
therefore placing the hydroxyl of C-11 below the B ring. This is in agreement with the NOE 
correlations seen for the brominated analogue, hamigeran J (44). Assuming the same absolute 
configuration, as the other hamigerans, the configuration of debromohamigeran J (62) is 5R, 6R, 
9R, 11S. The optical rotation data gave a rotation of the same sign as the hamigeran J (44).48 
 
 
Figure 3.16. Key NOE correlations for debromohamigeran J (62). 
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Table 3.4. NMR data (600 MHz) of debromohamigeran J (62) in CDCl3. 
 
   13C     1H   
 
HMBC 
 Position  (ppm) mult. 1JCH (Hz)  (ppm) mult. 3JHH (Hz) COSY (1H → 13C) NOESY 
1 156.0 C 
       1-OH 
   
6.86 br s 
  
1, 2, 11a 
 2 116.3 CH 158 6.68 s 
 
4, 17 1, 4, 11a, 16 16 
3 140.4 C 
       4 123.6 CH 159 6.65 s   4, 17, 5(w) 1, 3, 4a, 11a, 2, 11(w), 5, 16 5, 16, 6(w), 12 
4a 136.4 C 
       5 57.8 CH 130 3.42 d 9.1 4(w), 6 10, 4a, 4, 11a, 9, 6, 12, 7 4, 6, 7, 15 
6 51.0 CH 132 2.18 m 
 
5, 12(w), 7a 5, 9, 8, 12, 7, 13, 14 4(w), 5, 7, 15, 12, 13, 14 
7 26.3 CH2 130 a) 1.67 m 
 
6, 8b, 7b 5, 9, 6, 8, 12 5, 8a, 6 
 
   
b) 1.70 m 
 
8a, 8b, 7a 5, 9, 6, 8, 12 5, 6, 8b, 14 
8 35.1 CH2 129 a) 2.59 dt 7.2,13.1 7b, 8b 10, 5, 9, 6, 7 7a, 8a, 15, 14 
 
   
b) 1.45 m 
 
7a, 7b, 8a 10, 9, 6 8b, 7b 
9 54.7 C 
       10 209.2 C 
       11 78.1 C 
       11-OH 
   
5.09 br s 
  
10(w), 11a(w), 11(w) 
 11a 118.0 C 
       12 27.1 CH 125 1.29 s 
 
6(w), 13, 14 5, 6, 7, 13, 14 4, 6, 13, 14 
13 23.2 CH3 123 0.45 m   12 6, 12, 14 6, 14 
14 19.3 CH3 124 0.46 d 6.8 12 6, 12, 13 8a, 7b, 13 
15 26.1 CH3 128 1.34 d 6.8 
 
10, 5, 9, 8 18, 5, 8a, 6 
16 21.4 CH3 126 2.31 s 
  
3, 4, 2 2, 4, 18(w) 
17 169.9 C 
       18 53.6 CH3 149 3.72 s 
  
17 16(w), 15 
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3.4 Hamigeran L 12-O-methyl ester (63) 
 
Hamigeran L 12-O-methyl ester (63) was isolated as a colourless film. HRESIMS analysis 
established a molecular formula of C20H25O5Br (Δ = −0.77 ppm) from a [M+H]
+ adduct ion 
formula of m/z 427.111. Evidence of a bromine came from the equally intense [M+2+H]+ peak. 
Analysis of 13C and 1H NMR spectra coupled with HSQC showed that 12 of the 20 carbon 
resonances were attached to 23 of the 25 protons. Overall the carbons were identified as three 
methines [CH-5 (δC 53.8, δH 3.64); CH-6 (δC 50.6, δH 2.2); CH-13 (δC 30.1, δH 1.36)], three 
methylenes [CH2-10 (δC 43.2, δH 2.15, 1.84); CH2-8 (δC 36.3, δH 1.95, 1.81); CH2-7 (δC 29.6, δH 
2.18, 1.68)], four alkyl methyls [CH3-16 (δC 27.6, δH 1.27); CH3-17 (δC 24.2, δH 2.42); CH3-15 (δC 
22.3, δH 0.58); CH3-14 (δC 21.8, δH 0.87)] and a methoxy [CH3-18 (δC 52.6, δH 3.96)]. Also 
included were two carbonyls [C-11 (δC 177.5); C-12 (δC 170.5)], six olefinic sp
2 carbons [C-1 (δC 
155.5); C-3 (δC 142.5); C-4a (δC 141.5); CH-4 (δC 123.0, δH 6.54); C-12a (δC 115.9); C-2 (δC 111.5)] 
and a quaternary carbon C-9 (δC 46.1). The remaining two protons were identified as 
exchangeables, one as the phenol proton 1-OH (δH 9.9), with the other not observed in the 
1H 
NMR spectrum. The molecular formula indicated seven degrees of unsaturation, five of which 
were identified as the two carbonyls and the six olefinic carbons suggesting the structure is 
bicyclic, different from the previous three tricyclic compounds. 
Substructures 1, 2 and 3 were identified in the same way as previously with minor changes noted 
for substructure 1 (Figure 3.17). The phenol showed only weak HMBC correlations to C-1, C-2 
and C-12a with a weak HMBC correlation from CH-4 to the carbonyl C-12 used to identify the 
substituent attached to C-12a. No COSY correlation was observed from CH-5 to CH-4 with 
assignments identified from HMBC correlations instead. The carbon C-2 did not have a proton 
unlike the last three described structures, instead it was bonded to bromine like the more 
commonly isolated hamigerans with this supported by the 13C chemical shift of C-2 and C-1.     
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Figure 3.17. Substructures 1, 2 and 3 of hamigeran L 12-O-methyl ester (63). 
The substructures along with the isolated methyl CH3-16 and the quaternary carbon C-9 were 
assembled together via the same bonds as before (Figure 3.18). HMBC and COSY correlations 
identified the bonds from CH-5 to CH-6, CH-6 to CH-13 and evidence of the cyclopentyl ring 
from the CH-5, C-9 and CH2-8 linkage. The remaining bond to C-9 was identified as that to 
methylene CH2-10 by a HMBC correlation from CH3-16.  
 
 
Figure 3.18. Key HMBC and COSY correlations connecting the three substructures and 
forming the cyclopentyl ring of hamigeran L 12-O-methyl ester (63). 
The remaining atoms after these assignments were carbonyl C-11, methoxy CH3-18 and a 
hydroxyl. An HMBC correlation from CH3-18 to the carbonyl C-12 identified its connectivity as 
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part of an ester. Evidence for the bond between the methylene CH2-10 and the carbonyl C-10 
was established by HMBC correlations from CH2-10 (Figure 3.19). Based on the 
13C chemical 
shift of carbonyl C-10 and the molecular formula it was determined the remaining hydroxyl was 
attached to C-11, as part of a carboxylic acid. With the molecular formula fully assigned and all 
bonds accounted for the planar structure was complete (Figure 3.20). 
 
Figure 3.19. Key HMBC correlations of CH2-10 and CH3-18 for  
hamigeran L 12-O-methyl ester (63). 
 
Figure 3.20. Completed planar structure of hamigeran L 12-O-methyl ester (63). 
This new compound is a methyl ester analogue of the known hamigeran L (49) and is isomeric 
with hamigeran L 11-O-methyl ester (50). Only the standard three stereogenic centres were 
present in hamigeran L 12-O-methyl ester (63) with NOE correlations indicating the usual 
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configurations for CH-5, CH-6, CH3-16 like the rest of the series, giving the absolute 
configuration of 5R, 6R, 9R (Figure 3.21). The optical rotation data gave a rotation of the same 
sign and order as the hamigeran L (49) and hamigeran L 11-O-methyl ester (50).48 
 
Figure 3.21. Key NOE correlations for hamigeran L 12-O-methyl ester (63). 
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Table 3.5. NMR data (600 MHz) of hamigeran L 12-O-methyl ester (63) in CDCl3. 
 
 
  13C     1H   
 
HMBC 
 Position  (ppm) mult. 1JCH (Hz)  (ppm) mult. 3JHH  (Hz) COSY (1H → 13C) NOESY 
1 155.5 C 
       1-OH 
   
9.90 
   
1(w), 12a(w), 2(w) 
 2 111.5 C 
       3 142.5 C 
       
4 
123.0 CH 160 6.54 
  
17 
12(w), 1(w), 4a(w), 12a, 2, 5, 
17 17, 8a, 7b, 13 
4a 141.5 C 
       5 53.8 CH 125 3.64 d 7.2 6 4a, 4, 12a, 6, 9, 8, 7, 16 6, 16, 15 
6 50.6 CH 122 2.20 m 
 
5, 7a(w) 4a, 5, 13, 7, 14, 15 5, 7b, 16, 14, 15 
7 
29.6 CH2 126 a) 2.18 m 
 
6(w), 8b, 8a(w), 
7b(w) 5(w), 5(w), 8(w) 10b, 7b,16 
 
  
126 b) 1.68 m 
 
8b, 7a(w) 6(w), 8(w) 4, 6, 7a 
8 36.3 CH2 122 a) 1.95 m 
 
7a(w), 8b 9, 10, 7(w), 16 4, 8b 
 
  
122 b) 1.81 m 
 
7a, 7b, 8a 6(w), 5(w), 9(w), 16(w) 8a 
9 46.1 C 
       10 43.2 CH2 127 a) 2.15 d 14.7 10b 11, 5(w), 9, 8, 16 10b 
 
  
127 b) 1.84 d 14.7 10a, 16(w) 11, 5(w), 9, 8, 16(w) 10a, 7a, 16 
11 177.5 C 
       12 170.5 C 
       12a 115.9 C 
       13 30.1 CH 123 1.36 m 
 
14, 15 6, 14, 15 4, 14, 15 
14 21.8 CH3 121 0.87 d 6.4 13 6, 13, 15 6, 13, 15 
15 22.3 CH3 121 0.58 d 6.4 13 6, 13, 14 5, 6, 13, 14 
16 
27.6 CH3 121 1.27 s 
 
10b(w) 11, 5, 9, 10, 8 
18(vw), 5, 6, 7a, 
8b 
17 24.2 CH3 125 2.42 s 
 
4 3, 4, 2 4 
18 52.6 CH3 147 3.96 s 
  
12 16(vw) 
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3.5 4-Bromohamigeran A (64) 
 
4-bromohamigeran A (64) was isolated as a pale yellow film. HRESIMS analysis gave a [M+H]+ 
adduct ion m/z 503.0063 suitable for the formula C20H24Br2O4 (Δ = −0.62 ppm). Evidence for a 
dibrominated compound came from a 1:2:1 ratio of the [M+H]+, [M+2+H]+ and [M+4+H]+ 
peaks. Analysis of the 1H, 13C and HSQC NMR spectra revealed that 22 of the 24 protons were 
attached to ten of the 20 carbons. This included three methines [CH-5 (δC 54.2, δH 3.82); CH-6 
(δC 47.6, δH 2.8); CH-12 (δC 27.7, δH 1.39)], two methlyenes [CH2-8 (δC 37.4, δH 1.69, 1.49); CH2-
7 (δC 23.6, δH 1.81, 1.57)] and four methyls [CH3-16 (δC 26.3, δH 2.75); CH3-14 (δC 24.5, δH 0.78); 
CH3-15 (δC 23.6, δH 1.31); CH3-13 (δC 16.7, δH 0.09)] and a methoxy [CH3-18 (δC 53.4, δH 3.59)]. 
The other ten carbons were non-protonated centres, including two carbonyls [C-11 (δC 197.9); 
C-17(δC 169.7)] six olefinic sp
2 carbons [C-1 (δC 155.4); C-3 (δC 148.3); C-4a (δC 145.0); C-4  
(δC 117.9); C-11a (δC 114.9); C-2 (δC 111.0)] and two sp
3 quaternary carbons [C-10 (δC 85.3); C-9 
δC 47.6)]. The other two protons were assigned as exchangeables [1-OH (δH 11.38); 10-OH (δH 
4.22)]. The molecular formular indicated eight degrees of unsaturation which could be accounted 
for from two carbonyls, six olefinics and a tricyclic structure. 
The lack of aromatic proton resonances, two bromines and six non-protonated sp2 carbons 
suggested a fully substituted aromatic ring for substructure 1 with H-4 replaced with a second 
bromine. This assignment was supported by the usual HMBC correlations from the three 
aromatic substituents, the proton from the phenol 1-OH, the aromatic methyl CH3-16 and the 
methine, CH-5. A weak HMBC correlation from 1-OH also identified C-11a was connected to 
the carbonyl C-11 (Figure 3.22). Substructures 2 and 3 remained unchanged and were connected 
together along with substructure 1, the ring junction methyl CH3-15 and the quaternary carbon 
C-9 in the usual fashion (Figure 3.23). The remaining bond to C-9 was identified as the 
methylene carbon C-10 by an HMBC correlation from CH3-15. 
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Figure 3.22. Key HMBC and COSY correlations establishing substructures 1, 2 and 3 of  
4-bromohamigeran A (64). 
 
Figure 3.23. Key HMBC and COSY correlations connecting the substructures together and 
establishing the cyclopentyl ring of 4-bromohamigeran A (64). 
The remaining atoms included a carbonyl, a methoxy and a hydroxyl. The hydroxyl had 
surprisingly strong HMBC correlations to its connection point C-10, and to C-9 and C-11, 
establishing the final ring in the tricyclic structure (Figure 3.24). A weak HMBC correlation from 
10-OH established the bond between C-10 and the carbonyl C-17 and an HMBC correlation 
from CH3-18 to C-17 established it to be part of a methyl ester. With this, the planar structure 
was complete (Figure 3.25). 
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Figure 3.24. Key HMBC correlations for C-10 and C-18 of establishing the methyl ester of 
 4-bromohamigeran A (64). 
 
Figure 3.25. Completed planar structure of 4-bromohamigeran A (64). 
 
NOE correlations between CH-5, CH-6 and CH3-15 confirmed the usual relative configuration 
of the stereogenic centres (Figure 3.26). A NOE correlation between CH3-15 and CH3-18 
indicated the methyl ester was sitting above the ring with the hydroxyl below, consistent with the 
other 4-bromohamigerans (64), hamigeran A (28) and debromohamigeran A (29). This gives the 
absolute configuration as 5S, 6R, 9R, 10R. The optical rotation data gave a rotation of the same 
sign and order as the hamigeran A (28) and debromohamigeran A (29). 
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Figure 3.26. Key NOE correlations for 4-bromohamigeran A (64).
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Table 3.6. NMR data (600 MHz) of 4-bromohamigeran A (64) in CDCl3. 
 
 
  13C     1H   
 
HMBC 
 Position  (ppm) mult. 1JCH (Hz)  (ppm) mult. 3JHH (Hz) COSY (1H → 13C) NOESY 
1 155.4 C 
       1-OH 
   
11.38 s 
  
11(w), 1, 11a, 2 
 2 111.0 C 
       3 148.3 C 
       4 117.9 C 
       4a 145.0 C 
       5 54.2 CH 135 3.82 d 10.4 6 4a, 4, 11a, 2(w), 10, 6, 9, 8, 12, 7 6, 15 
6 47.6 CH 130 2.80 tt 9.7, 2.4 5, 7a, 7b(w) 4a(w), 5(w), 8, 12, 14, 7, 13 5, 15, 7a, 12, 14 
7 23.6 CH2 131 a) 1.81 m 
 
6, 8a 6, 9, 8, 12 6, 7b, 15 
 
  
131 b) 1.57 m 
 
6(w), 8b) 5, 6, 9, 8, 12 7a, 14 
8 37.4 CH2 127 a) 1.69 m 
 
7a, 8b(w) 5, 6, 9, 15 8b, 14 
 
  
127 b) 1.49 m 
 
8a(w), 7b 10, 6, 9, 15 8a, 12 
9 47.6 C 
       10 85.3 C 
       10-OH 
   
4.22 Br s 
  
11, 17(w), 10, 9 
 11 197.9 C 
       11a 114.9 C 
       12 27.7 CH 121 1.39 m 
 
13, 14 5(w), 6, 14, 8, 12 6, 13, 14 
13 16.7 CH3 123 0.09 d 6.75 12 6, 12, 14 7a, 8b, 12, 14 
14 24.5 CH3 123 0.78 d 6.75 12 6, 12, 13 6, 8a, 7a, 7b, 14 
15 23.6 CH3 126 1.31 s 
  
10, 5, 9, 8 5, 6, 18, 7a, 8a 
16 26.3 CH3 130 2.75 s 
  
11(w), 3, 4a(w), 4, 2 
 17 169.7 C 
       18 53.4 CH3 149 3.59 s 
  
17 15 
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Chapter 4: Novel Hamigerans from Hamigera tarangaensis 
4.1 Hamigeran R (61) 
 
Hamigeran R was isolated as a colourless film. Positive ion HRESIMS analysis of a [M+NH4]
+ 
adduct ion at m/z 411.1280 indicated a molecular formula of C19H24BrNO3 (Δ = +0.52). The 
presence of bromine was evident by a [M+2+NH4]
+ peak in a 1:1 ratio. At first it could not be 
determined if it was a [M+H]+ ion with a molecular formula of C19H27BrN2O3 or a [M+NH4]
+ 
ion with a molecular formula of C19H24BrNO3 due to the same masses. To identify the correct 
molecular formula, negative ion HRESIMS analysis was required, which produced a [M−H]− 
adduct ion, m/z 392.0874 with a molecular formula C19H24BrNO3 (Δ= −1.83 ppm ) establishing 
that only one nitrogen was present in the compound. Analysis of 13C and 1H NMR with HSQC 
data identified 11 of the 19 carbon were attached to 22 of the 24 protons, the remaining two 
protons identified as exchangeable protons were not observed in the 1H NMR spectrum. Overall 
these signals included four methyls [CH3-16 (δC 27.9, δH 1.34); CH3-17 (δC 24.5, δH 2.45); CH3-14 
(δC 22.2, δH 0.88); CH3-15 (δC 22.1, δH 0.69)], three methylenes [CH2-10 (δC 43.3, δH 2.15, 1.82); 
CH2-8 (δC 36.6, δH 1.81, 1.87); CH2-7 (δC 29.1, δH 1.67, 1.84)], three methines [CH-5 (δC 56.5, δH 
3.4); CH-6 (δC 50.5, δH 2.31); CH-13 (δC 30.4 δH 1.23)], a carbonyl [C-11 (δC 176.9)], six sp
2 
olefinic carbons [C-1 (δC 155.2); C-4a (δC 145.2); C-3 (δC 143.5); CH-4 (δC 123.0, δH 6.62); C-2 (δC 
111.1); C-12a (δC 101.6)], an unusually shifted  C-12 (δC 115.3) and a quaternary sp
3 carbon [C-9 
(δC 46.5)]. The molecular formula required eight degrees of unsaturation, four were identified as 
the carbonyl and the six olefinic carbons, with the remaining four unaccounted. 
The aromatic ring of substructure 1 was monobrominated and identified in a similar fashion to 
the other monobrominated compound hamigeran L 12-O-methyl ester (63) with the exception 
of the phenol proton not being observed in the 1H NMR spectrum (Figure 4.1). The sequence of 
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C-2, C-1 and C-12a was instead identified by HMBC correlations from the aromatic methyl CH3-
17 and CH-4. The unusually shifted carbon C-12 (δC 115.3) was established to be connected to 
C-12a by a weak HMBC from CH-4. Allylic COSY coupling was only observed between CH3-17 
and CH-4, not onto CH-5 which is often suggestive of an open B ring hamigeran. Substructures 
2 and 3 remained unchanged. 
 
Figure 4.1. Key HMBC and COSY correlations establishing substructures 1, 2 and 3  
of hamigeran R (61). 
The three substructures were connected in the usual fashion with bonds of CH-5 to CH-6 and 
CH-6 to CH-13 confirmed with COSY and HMBC correlations. The cyclopentyl ring was 
established though HMBC correlations from CH3-16 to CH-5, C-9 and CH2-8. The remaining 
HMBC correlation identified the methylene CH2-10 as the remaining carbon bonded to C-9. 
HMBC correlations from CH2-10 established its connectivity to carbonyl C-11 (Figure 4.2). 
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Figure 4.2. Key HMBC and COSY correlations connecting substructures 1, 2 and 3 together 
along with the junction methyl CH3-16 and CH2-10 of hamigeran R (61). 
At this stage, all the atoms except for a nitrogen, an oxygen and two exchangeable protons were 
assigned. There were also two degrees of unsaturation unaccounted for. The 13C chemical shift 
for C-12 (δC 115.3) suggested this compound was not like the other nitrogenous hamigerans  
(δC ~160.0) isolated previously.
41,50 This shift and the remaining two degrees of freedom led to 
the possibility that this carbon and the nitrogen were a nitrile functionality. Comparing the 13C 
aromatic shifts of hamigeran R (61) to benzonitrile and 2-hydroxybenzonitrile indicated that they 
have a high degree of similarity (Table 4.1). The presence of the nitrile able to explain the 
disruption to the electronic structure of the aromatic ring and the upfield shift of C-12a. 
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Table 4.1. NMR 13C shift comparison of aromatic nitriles and hamigeran R (61) in CDCl3. 
 
 
 
 
 
 
Conclusive evidence of the nitrile came from of an IR spectrum. IR was first performed on 
several known compounds including hamigeran A (28) and hamigeran B (30) to gauge the 
spectrophotometers sensitivity, then on hamigeran L 11-O-methyl ester (50), as a close 
comparison to hamigeran R (61). The IR spectrum of hamigeran R (61) contained several peaks 
in common with the other hamigerans along with a small sharp peak at 2223 cm-1 (Figure 4.3). 
This peak is indicative of a carbon-nitrogen triple bond stretch, a very distinctive stretch not 
observed in any of the other hamigerans. The IR also revealed a broad peak at 3226 cm-1, typical 
of a hydroxyl stretch. This leads to the conclusion at least one hydroxyl is present in the 
compound.   
The 13C and 1H shifts of CH2-10 and C-11 of hamigeran R (61) are nearly identical to hamigeran 
L 12-O-methyl ester (63), which is part of a carboxylic acid at C-11. Alternatively hamigeran L 
11-O-methyl ester (50) is part of an ester at C-11 and the chemical shifts are significantly 
different indicating that C-11 for hamigeran R (61) is part of a carboxylic acid. The final proton 
could be assigned as part of the phenol 1-OH, its absence in the 1H NMR due to lack of 
hydrogen bonding. With this finalised, the planar structure for hamigeran R (61) was complete 
(Figure 4.4). 
position hamigeran R (61) 2-hydroxybenzonitrile benzonitrile 
C-1 155.1 159.2 132.1 
C-2 111 116.7 129.2 
C-3 143.4 134.9 132.8 
C-4 123 120.8 129.2 
C-4a 145.3 133.1 132.1 
C-12 115.3 116.7 118.8 
C-12a 101.5 99.3 112.4 
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Figure 4.3. IR spectrum of hamigeran R (61). 
 
 
Figure 4.4. Completed planar structure of hamigeran R (61). 
NOE correlations between CH-5, CH-6 and CH3-16 revealed the standard relative configuration 
in hamigeran R (61), like the rest of the hamigerans with the proposed absolute configuration 
being 5R, 6R, 9R (Figure 4.5) 
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Figure 4.5. Key NOE correlations establishing the relative configuration of hamigeran R (61). 
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Table 4.2. NMR data (600 MHz) of hamigeran R (61) in CDCl3. 
 
 
 
  13C     1H   
 
HMBC 
 Position  (ppm) mult. 1JCH (Hz)  (ppm) mult. 3JHH (Hz) COSY (1H → 13C) NOESY 
1 155.2 C 
       2 111.1 C 
       3 143.5 C 
       4 123.0 CH 161 6.62 
  
17 1(w), 4a(w), 12(w), 2, 12a, 5, 17 17, 8b, 7a, 13 
4a 145.2 C 
 
 
     5 56.5 CH 131 3.40 d 7 6 4a, 4, 12a, 6, 9, 8, 7, 16 6, 10a(w), 16, 15 
6 50.5 CH 125 2.31 m 
 
5, 7a(w), 13(w) 4a(w), 5, 13, 7(w), 14, 15 5, 16, 14, 15 
7 29.1 CH2 123 a) 1.67 m 
 
5(w), 8a(w), 7(b) 6, 8, 9, 13 4, 10a, 14, 8b 
 
  
120 b) 1.84 m 
 
7a) 5, 6, 9, 8, 16 16 
8 36.6 CH2 125 a) 1.81 m 
 
7a(w), 8b(w) 5, 6, 9, 7, 16 16, 10b, 8b 
 
  
125 b) 1.87 m 
 
8a(w) 6, 9, 7, 16 4, 16, 8a, 7a(w) 
9 46.5 C 
 
 
     10 43.3 CH2 127 a) 2.15 d 14.4 10a 11, 5, 9, 8, 16 10b, 7a, 16, 14(w) 
 
  
127 b) 1.82 d 14.4 10b 11, 5, 6, 9, 8, 16 10a 
11 176.9 C 
 
 
     12 115.3 C 
 
 
     12a 101.6 C 
 
 
     13 30.4 CH 126 1.23 m 
 
6(w), 14, 15 5, 6, 14, 15, 7 4, 7a(w), 14, 15 
14 22.2 CH3 124 0.88 d 6.5 13 6, 13, 15 6, 10a(w), 7a, 13 
15 22.1 CH3 124 0.69 d 6.5 13 6, 13, 14 5, 6, 13 
16 27.9 CH3 127 1.34 s 
  
5, 9, 10, 8 5, 6, 8b, 10a 
17 24.5 CH3 129 2.45 s 
 
4 1(w), 3, 4, 2, 12a(w) 4 
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4.2 Hamigeran S (65) 
 
Hamigeran S (66) was isolated as a faintly yellow film. The positive ion HRESIMS analysis 
showed two ions, a [M+H]+ adduct ion at m/z 738.1788 and half  as abundant, a [M+Na]+ 
adduction at m/z 798.1812 indicating a molecular formula of either C38H45Br2NO4 (Δ = −1.64 
ppm) or C38H49Br2NO6 (Δ = -1.22 ppm). Two bromines were evident from the 1:2:1 ratio of 
both masses [M+H]+, [M+2+H]+ and [M+4+H]+ peaks (or Na+ for the higher mass). Neither 
mass was observed in negative ion mode. 
Analysis of the 1H and 13C NMR data with the use of multiplicity-edited HSQC NMR spectra 
revealed 19 carbon signals, with 11 of the carbons connected to 22 protons, far short of either of 
the molecular formula given by the HRESIMS. Overall three methines [CH-5 (δC 49.7, δH 3.34); 
CH-6 (δC 49.7, δH 2.14); CH-13 (δC 28.5, δH 2.01)], three methylenes [CH2-10 (δC 51.1, δH 2.13, 
2.38); CH2-8 (δC 36.6, δH 1.48, 1.58); CH2-7 (δC 27.1, δH 1.84, 2.02)] and four methyls [CH3-16 (δC 
25.9, δC 1.14); CH3-17 (δC 23.5, δH 2.31); CH3-14 (δC 23.0, δH 0.49); CH3-15 (δC 22.9, δH 0.91)], a 
carbonyl C-11 (δC 199.9), six olefinic sp
2 [C-1 (δC 149.8); C-3 (δC 139.9); C-4a (δC 138.1); CH-4 
(δC 122.5, δH 6.91); C-12a (δC 118.6); C-2 (δC 110.8)] and two sp
3 quaternary carbons [C-12 (δC 
83.8); C-9 (δC 44.5)] were detected. Four degrees of unsaturation were initially identified, three 
from the six olefinic carbons and one from the carbonyl. This mismatch between NMR spectra 
and the HRESIMS formula was perplexing. It is not unusual for compounds to form unusual 
adducts during HRESIMS including additional water molecules or dimerization. NMR analysis 
therefore became critical in confirming if hamigeran S (66) was truly a dimer or a species 
generated in situ in the HRESIMS.  
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Like the previous compound, substructure 1 contained a monobrominated aromatic ring with no 
phenolic proton present in the 1H NMR spectra (Figure 4.6). HMBC correlations from CH3-17, 
CH-4 and CH-5 were used to identify the aromatic ring and its substituents including the 
quaternary carbon C-12. Substructures 2 and 3 remained the same and the three substructures 
were assembled together in the typical fashion seen in the previous six compounds (Figure 4.7). 
HMBC correlations from the methyl CH3-16 were used to identify the cyclopentyl ring and the 
bond between C-9 and the methylene CH2-10. Unusually there was W coupling detected 
between CH3-16 and one of the protons of CH2-10 (10b) in the COSY spectrum. This coupling 
is not usually observed because of the flexibility of the seven carbon B ring, suggesting there was 
some conformational restriction in this case. HMBC correlations from CH-10b identified the 
connection to the carbonyl C-11 and the carbonyls connection to the quaternary carbon C-12, 
establishing the seven carbon B ring and completing a tricyclic structure. 
 
Figure 4.6. Key HMBC and COSY correlations establishing substructures 1, 2 and 3  
of hamigeran S (65). 
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Figure 4.7. Key HMBC and COSY correlations connecting the substructures together, forming 
the cyclopentyl ring and B ring of hamigeran S (65). 
The remaining two unassigned bond equivalents from carbon C-12 and one bond equivalent to 
the oxygen attached to C-1 could not be identified from the standard NMR experiments in 
CDCl3. To identify whether either of these sites had exchangeable protons, a drop of a 1:1 
H2O/D2O was added to a NMR tube of hamigeran S (65) in CDCl3. This showed what appeared 
to be a splitting or broadening of carbons nearby exchangeable protons in the 13C NMR 
spectrum. This splitting is due to the deuterium isotope effect on the chemical shift, with half of 
the exchangeable protons switched with deuterium, resulting in two peaks at half the height it 
was previously. It was expected that C-1 would show this splitting from the phenol 1-OH, with 
smaller splitting for C-2 and C-12a. However a splitting of C-12, with minor splitting for C-12a 
and C-11 was instead observed . This evidence suggested there was no exchangeable proton on 
the oxygen attached to C-1, but instead an exchangeable on a heteroatom attached to C-12. 
The addition of the drop of H2O/D2O also resulted in a new peak appearing in the 
1H NMR 
spectrum as a broad singlet (δH 3.06). Integration of the peak showed it was a quarter the size of 
a proton from the remainder of hamigeran S (66). When this was repeated with a drop of H2O 
the peak integrated for half a relative proton. A rationale to this observed phenomenon would be 
that this exchangeable proton is in the centre of a C2 symmetric dimer, with all the other protons 
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doubled. To follow up this line of reasoning , an IR spectrum was obtained revealing a small 
single peak at 3300 cm-1, which matches the N-H stretch of a secondary amine, typically of one 
band between 3350 – 3310 cm-1 (Figure 4.8). No broad OH stretching was present, supporting 
the results of the H2O/D2O experiment which suggested the presence of only one exchangeable 
proton. The nitrogen, with its proton would be at the centre of the dimer, explaining why it can 
be singular in a C2 symmetric dimer. 
 
Figure 4.8. IR spectrum of hamigeran S (65). 
 As a final technique to prove the presence of an N-H in hamigeran S, the NMR spectra were 
rerun in DMSO-d6. This time, the N-H proton was observable without added H2O, integrating 
for half a relative proton as expected. 15N HSQC and HMBC data were also collected. A strong 
correlation with HSQC between the nitrogen and the exchangeable proton [12-NH (δN -317.9,  
δH 5.46)] confirmed their connectivity. HMBC correlations from exchangeable proton 11-NH to 
C-11, C-12a and C-4a confirmed their connectivity to the rest of the carbon skeleton, placing 
them in the centre of the dimer (Figure 4.9).  
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Figure 4.9. Key HMBC correlations for N-H of hamigeran S (65). 
Only two bonds remained unaccounted for in each half of the dimer, from the oxygen attached 
to C-1 and a bond at C-12. Three possible dimer structures could be proposed at this point for 
the connectivity of these bonds, but two could be eliminated from contradicting evidence leaving 
just one correct solution (Figure 4.10). The structure 65a matched the higher ion mass given by 
the HRESIMS, [M+Na]+ ion m/z 798.1812 with the formula C38H49Br2NO6 but did not match 
the NMR data for the 1:1 H2O/D2O experiment or the DMSO experiment which determined 
that there is only one exchangeable proton was present under NMR conditions. The IR also 
suggested that no hydroxyls are present under standard conditions. It is possible that this 
structure may exist under HRESIMS conditions.  
The structure 65b could also be eliminated, it has σh symmetry but this would require an 
inversion of configuration of the three stereogenic centres CH-5,CH-6 and C-9 on one half of 
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the molecule. This was thought of as extremely unlikely with all hamigerans found to date 
retaining the configuration of these centres. It also appears that it would contain C2 Symmetry 
but this is only when drawn planar. A 3D model would place the aminal ring perpendicular to 
the rest of the structure, destroying any rotation symmetry. Furthermore the four membered 
aminal ring, while not impossible, would also be quite strained and not favoured.  
This left the structure 65c which matched the molecular formula of the lower mass given by the 
HRESIMS [M+H]+ ion at m/z 738.1788, C38H45Br2NO4, was consistent with the 1:1 H2O/D2O 
experimental results, the IR and was C2 symmetric (though a 180° rotation though the N-H 
bond). A literature search revealed a synthesis of several dioxocin and dithiocin, aminal 
containing dimers including a dinaphthol compound with comparable carbon shifts to 
hamigeran S (65) (Table 4.3).51 The main difference in shifts results from the dioxocin having a 
tertiary carbon instead of quaternary bonded to the aminal. With the correct bonding identified, 
the planar structure of hamigeran S (65) was complete (Figure 4.11) and establishing the first 
hamigeran dimer ever found. 
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   65a     65b    65c  
Figure 4.10. Possible planar structures for hamigeran S (65). 
 
Table 4.3. NMR 13C shift comparison of aminals in CDCl3. 
 
 
 
 
 
 
position hamigeran S (66) 8,16-Imino-dinaphthol-1-5-dioxocin 
C-1 149.3 150.3 
C-12 83.2 75.6 
C-12a 117.4 118.3 
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Figure 4.11. Completed planar structure of hamigeran S (65). 
NOE correlations were used to determine the relative configuration of hamigeran S as in all the 
previous hamigerans (Figure 4.12). NOE correlations showed the protons of CH-5, CH-6 and 
CH3-16 were all on the same side of the compound, giving the typical cis-fused B and C rings 
with the isopropyl tail sitting below the ring. Furthermore CH-5 and CH3-16 showed NOE 
correlations to the proton H-10a, placing it on the same side of the molecule as these centres. 
This assignment was confirmed COSY data mentioned before which placed H-10b on the 
opposite face to H3-16 from W coupling. H-10b showed a weak NOE correlation to the N-H 
while H-10a did not. Peaks in the 1D ROESY supported these correlations indicating that the 
12-NH sits below the ring.  The absolute configuration of the eight stereogenic centres in 
hamigeran S is therefore proposed to be 5R, 6R, 9R, 12R, 5’R, 6’R, 9’R, 12’R.  
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Figure 4.12. Key NOE correlations establishing the relative configuration of 
 hamigeran S (65).  
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Table 4.4. NMR data (600 MHz) of hamigeran S (65) in DMSO-d6. 
 
 
 
 
  13C/15N     1H   
 
HMBC 
 Position  (ppm) mult. 1JXH (Hz)  (ppm) mult. 3JHH  (Hz) COSY (1H --> 13C) NOESY 
1 149.8 C 
  
     1-OH 
  
  
     2 110.8 C 
  
     3 139.9 C 
  
     
4 
122.5 CH 
160 6.91 
s 
 
5, 17 
1(w), 3(w), 4a(w), 12a, 2, 12, 5, 
17 
17, 6, 13, 7a, 5, 14(w), 
15(w) 
4a 138.1 C 
  
     5 49.7 CH 131 3.34 d 5.8 4, 6, 8b(w) 4a, 4, 12a, 6, 9, 8, 7, 16 4, 6, 16 
6 49.6 CH 126 2.14 m 
 
5 5, 9, 13, 14, 15 4, 5, 16, 7b, 13 
7 27.1 CH2 120 a) 1.84 m 
 
7b, 8b 6, 9, 8, 13 4, 7b, 8a, 8b 
 
  
 
b) 2.02 m 
 
7a, 8a, 8b 6, 5, 8 6, 7a, 8a, 8b 
8 36.6 CH2 129 a) 1.48 m 
 
7b, 8b, 16 10, 9, 7, 16 10b, 10a(w), 7a 
 
  
 
b) 1.58 
m 
 
5(w), 7b, 7a, 
8a 6, 9, 16 10b(w), 10a, 7a 
9 44.5 C 
  
     10 51.1 CH2 129 a) 2.13 d 10.7 10b 11, 12a, 12, 9, 16 12N, 10b, 8a(w), 8b 
 
  
 
b) 2.38 d 10.7 10a, 16 11, 9, 8, 16 12N, 10a, 8a, 8b(w) 
11 199.9 C 
  
     12 83.8 C 
  
     
 
-317.9 NH 78.5 5.46 
   
11, 4a(w), 12a 10a, 10b 
12a 118.6 C 
  
     13 28.5 CH 125 2.01 m 
 
14, 15 14, 15, 6, 5, 7 4, 6, 15, 14 
14 23.0 CH3 122 0.49 d 6.1 13 6, 13, 15 13, 4(w) 
15 22.9 CH3 122 0.91 d 6.1 13 6, 13, 14 13, 4(w) 
16 25.9 CH3 125 1.14 s 
 
10b, 8a 10, 5, 9, 8 5, 6 
17 23.5 CH3 127 2.31 s 
 
4 3, 4, 2 4 
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4.3  Proposed biogenesis  
 
Hamigeran R (61) and hamigeran S (65) are believed to originate from a similar biogenesis. Like 
all other nitrogenous hamigerans isolated to date, except possibly hamigeran M (51), there seems 
to be a common precursor in hamigeran G (40). The difference with hamigeran R (61) and 
hamigeran S (65) is that instead of reacting with an amino acid, they react with ammonia. A 
proposed biogenesis is shown in Scheme 4.1.  
To produce hamigeran R (61), first imine formation occurs at the ketone C-12. This imine then 
undergoes a Baeyer-Villiger type reaction, inserting an oxygen in between the imine and the 
other ketone. This reaction also may occur in hamigeran B (30) in forming hamigeran E (35) and 
to hamigeran G (40) in forming hamigeran L (49). Biological systems have been known to 
perform this reaction with Baeyer-Villiger monooxygenases.52 This intermediate, a carboximidate 
anhydride, could undergo an electrocyclic ring opening forming a nitrile and carboxylic acid. 
There is little to no evidence in the literature that Baeyer-Villiger reactions can occur to imines 
which may suggest the reaction first forms an anhydride then reacts with ammonia, but this too 
has little literature support. The formation of the nitrile is worth further investigation. 
The mechanism for hamigeran S (65) starts with the formation of the imine. The enhanced 
electrophilicity of the imine makes it susceptible to attack from a phenol of a second equivalent 
of hamigeran G (40), forming a hemiaminal. One the amine is reformed, it is then able to attack 
the ketone on the second hamigeran G (40) molecule. This results in the formation of a new ring 
and the second hemiaminal formation. The loss of water from the hemiaminal once again forms 
an imine. The new imine is trapped intramolecularly by the remaining phenol, forming a final 
hemiaminal, completing the structure of hamigeran S (65). A similar mechanism was proposed 
by Natividad for the synthesis of dithiocin imine and dioxocin imine compounds, for the aminal 
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compound in Table 4.3.51 Natividad’s mechanism is an improvement of a mechanism proposed 
by Biehl et al for the dimerization of 2-hydroxyl-1-naphthaldehyde with ammonium acetate.53 
 
Scheme 4.1. Proposed formation of new nitrogenous hamigerans. 
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Chapter 5: Synthetic work on the Hamigerans 
To test if the mechanism for the formation of hamigeran R (61) and hamigeran S (65) from 
hamigeran G (40) had any merit, some semi-synthesis was undertaken. During the isolation 
process, a workable amount (34.1 mg) of hamigeran G (40) was isolated providing the means to 
perform such reactions. This also gave the opportunity to investigate the biogenesis of the other 
nitrogenous hamigerans.  
5.1 Reaction of Hamigeran G (40) and Ammonium  
The first experiment was to see if an imine would form from the reaction of hamigeran G (40) 
with ammonia or with an ammonium source. The ketone closer to the aromatic ring (C-12) was 
thought to be more reactive with ammonia due its activation via hydrogen bonding with the 
phenol proton, making it more susceptible to nucleophilic attack. Formation of the imine could 
also lead to the spontaneous formation of hamigeran S (65), as based on the proposed 
mechanism of its biogenesis (scheme 4.1). An initial test was carried out by adding aqueous 
ammonia to a NMR tube containing hamigeran G (40), where the colour rapidly changed from 
bright yellow to dark red. 1H NMR analysis revealed a reaction had occurred, but the water 
resonance was obscuring several of the important signals with the reaction reverting before 
further NMR experiments could be acquired. A new ammonium source was used to counter this. 
The reaction of imine formation produces water but it was thought removal of any other water 
source would give significant conversion. Ammonium acetate in EtOH was initially chosen as it 
was the ammonium source used by Natividad in their synthesis of dithiocin imine and dioxocin 
imine compounds. However the acetate resonance obscured some of the hamigeran resonances 
in the 1H NMR spectrum, it was replaced with ammonium formate, as any excess could easily be 
removed under reduced pressure. 
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The reaction worked, with the 1H and 13C NMR spectra revealing the formation of the imine 
(66), with some hamigeran G (40), its minor configuration and hamigeran G enol (41) still 
present. The spectra were further complicated by other signals which appeared to be minor 
configuration and enol form of the imine (66). The reaction was repeated several times with 
increasing amounts of ammonium formate in an effort to favour the imine, with ten equivalents 
leading to the maximum amount converted. Without water the imine compound was relatively 
stable, taking several weeks to revert. Unfortunately, there was no sign of hamigeran S (65) 
present. The fact that the imine was able to be produced and was stable enough to acquire NMR 
data gave promise for further reactions.  
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Table 5. 1.  NMR data (600 MHz) of imine hamigeran (66) in CDCl3. 
 
 
 
  13C     1H   
 
HMBC 
Position  (ppm) mult. 1JCH (Hz)  (ppm) mult. 3JHH (Hz) COSY (1H → 13C) 
1 160.7 C 
      1-OH 
   
10.47 
    2 113.9 C 
      3 143.9 C 
      4 126.9 CH 
 
6.64 s 
 
17, 5 2, 12a, 5, 17, 3(w), 12(w), 1(vw), 4a(vw) 
4a 140.1 C 
      5 60.1 CH 
 
3.30 d 11 4, 6 1(w), 4a, 4, 12a, 6, 10, 9, 7, 13(w) 
6 54.0 CH 
 
1.91 m 
 
5, 13 7, 13, 14, 15, 5 
7 32.0 CH2 
 
a) 0.94 m 
 
8b, 7b(w) 8, 6, 13, 14, 15 
 
   
b) 1.70 m 
 
8b, 7a(w), 8a 5, 6(w), 9, 8(w) 
8 39.9 CH2 
 
a) 1.62 m 
 
8b, 7b(w) 10, 9, 7 
 
   
b) 1.91 m 
 
7b, 7a, 8a 9, 5, 10, 7, 6 
9 46.2 C 
      10 52.8 CH2 
 
a) 2.44 d 11 10a 11, 12, 5, 9, 8(w), 7(w) 
 
   
b) 2.68 d 11 10b 11, 9, 8, 7(w), 5(w) 
11 194.0 C 
      12 167.9 C 
      12a 115.7 C 
      13 29.1 CH 
 
0.91 m 
 
6, 14, 15 5, 6, 14, 15 
14 22.3 CH3 
 
0.36 d 5.8 13 6, 13, 15 
15 22.2 CH3 
 
0.66 d 6.9 13 6, 13, 14 
16 32.1 CH3 
 
1.31 s 
  
11(w), 5, 10, 9, 8 
17 23.7 CH3 
 
2.44 s 
 
4 2, 3, 4 
          
77 
 
5.2 Reaction of Hamigeran G (40) and L-Alanine  
Since the imine compound was stable, it was proposed that it may also be possible to form an 
amino acid imine (67) under the same conditions. It was theorized that the carboxylic acid would 
remain as unlike in the sponge, there would be no enzyme catalysing the decarboxylation or the 
reduction necessary for it to cyclise and produce hamigeran D (33). L-Alanine and hamigeran G 
(40) were mixed in ethanol in a 10:1 ratio, partly for higher conversion and partly because L-
alanine is not particularly soluble in ethanol. The reaction was refluxed for several hours with the 
colour noted changing from bright yellow to very pale yellow. It was then passed through an 
HP20 filter to remove any unreacted L-alanine and the crude reaction mixture analysed with 
NMR. Instead of compound 67 forming, hamigeran D (33) was observed, in what initially 
appeared to be an isomerically pure form (see below). This completely changed the 
understanding of the mechanism for the formation of the nitrogenous hamigerans. The reaction 
mixture was surprisingly pure. The only other compound being a small amount of hamigeran G 
enol (41), with no hamigeran G (40) or its minor conformer present, indicating the amino acid 
may only react with the diketone and not the enol form. 
   
67    33 
5.3 Reaction of Hamigeran G (40) and Glycine 
With the success of L-alanine it was decided that attempting a reaction between hamigeran G 
(40) with glycine would be beneficial. The oxazole hamigeran (51) is thought to have been 
produced from a reaction with glycine and a hamigeran. What is unknown is whether it was a 
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reaction with glycine and hamigeran G (40) (where it formed the oxazole functionality and was 
later oxidized at the C-10 position), or if it was a reaction with glycine and an as yet unidentified 
hamigeran. A reaction between glycine and hamigeran G (40) was carried out following the same 
procedure as before, the colour change from bright yellow to pale yellow was again observed and 
NMR used to identify the product (Table 5.2). The results indicated the formation of a new 
hamigeran (68), a synthetic nitrogenous hamigeran. It is plausible that compound 68 is produced 
by the sponge and is yet to be isolated. There was no indication of any oxazole containing 
compounds with the only minor compound present being hamigeran G enol (41) 
.    
51    68 
Compound 68 appeared in two conformations as is the case with many of the nitrogenous 
hamigerans. The heterocyclic ring can have either CH2-18 proton sitting pseudoaxial or 
psudoequatorial (Figure 5.1), which appears as two sets of doublets between 5 and 6 ppm 
(Figure 5.2). In cases with a carbon substituent such as a benzyl or isobutyl group as is the case 
with hamigerans (52) and (55), the conformer with the CH-18 proton pseudoaxial is 
predominantly observed in the 1H NMR spectra. This can be further complicated by the 
presence of nitrogenous epimers. When the configuration of CH-18 is reversed there is less 
preference in conformation with both conformers observed in almost equal amounts. In the case 
of compound 68 the preferred conformer cannot be confirmed. No NOE correlation between 
CH-13 to 18-HA was observed, which is what was used to assign the other conformers of the 
nitrogenous hamigeran compounds.  
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Figure 5.1. CH2-18 conformers for compound 68. 
 
 
Figure 5.2. 1H NMR spectrum of CH2-18 conformers for glycine compound 68.
80 
 
Table 5.2. NMR data (600 MHz) of glycine hamigeran (68) in CDCl3. 
 
 
 
 
  13C     1H   
 
HMBC 
 Position δ (ppm) mult. 1JCH (Hz) δ  (ppm) mult. 3JHH (Hz) COSY (1H → 13C) NOESY 
1 154.7 C 
       2 110.6 C 
       3 144.4 C 
       4 129.4 CH 161 6.84 s 
 
17, 5 2, 12a, 5, 17, 3(w), 12(w), 4a(w), 1(w) 17 
4a 138.3 C 
 
 
     5 59.3 CH 130 3.28 d 11 4, 6 4a, 4, 12a, 10, 6,9 ,16, 7, 13(w), 1(w) 6,16 
6 53.9 CH 123 1.94 m 
 
5, 7b, 7a, 13(w) 4a, 5, 7, 13, 14, 15 5,16 
7 31.8 CH2 131 a) 1.17 m 
 
6, 8b, 7a 6, 8, 13 
 
 
  
131 b) 1.73 m 
 
6, 7a, 8a 6, 8(w), 9 
 8 39.9 CH2 128 a) 1.59 m 
 
8b, 7a 5(w), 9, 10(w) 
 
 
  
128 b) 2.03 m 
 
7a, 8a 5(w), 10, 9, 8(w) 
 9 46.8 C 
 
 
     10 54.9 CH2 100 a) 2.66 d 11.2 10b 11, 5(w), 8, 9, 16 
 
 
  
105 b) 2.49 d 11.2 10a 11, 12, 5, 9, 8, 16 
 11 196.1 C 
 
 
     12 160.6 C 
 
 
     12a 117.8 C 
 
 
     13 29.6 CH 122 0.89 m 
 
6(vw), 14, 15 6, 14, 15, 5(w) 18a 
14 22.4 CH3 122 0.39 d 6.8 13, 15 13, 15, 6 
 15 22.1 CH3 122 0.68 d 6.8 13, 14 6, 13, 14 
 16 32.3 CH3 127 1.29 s 
  
5, 10, 9, 8 5,6 
17 23.3 CH3 127 2.45 s 
 
4 2, 3, 4 4 
 18 79.6 CH2 154 a) 5.04 d 11.2 18b 12, 1, 12a(w), 11  
    180 b) 6.09 d 11.2 18a 12, 1, 12a(w), 11(w)  
 18’    a) 5.01 d 10.5    
     b) 6.08 d 10.5    
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5.4 Reaction of Hamigeran G (40) and D-alanine 
One of the key steps in the mechanism for the formation of the nitrogenous hamigerans 
proposed by Singh (Scheme 3.2) involves the loss of configuration at C-18, meaning that the 
choice of L or D amino acid would not affect the outcome of the nitrogenous epimer produced. 
To test this, L-alanine was replaced with D-alanine and the experiment was repeated. The 
resulting 1H NMR spectra identified that both hamigeran D (33) and its C-18 epimer (70) were 
present. This is the first time this epimer has been observed as it yet to be isolated from a natural 
source. After purification of the L-alanine reaction mixture using HPLC, it became apparent 
there was a small amount of the epimer (69) present alongside hamigeran D (33). The ratios of 
hamigeran D (33) and its epimer (69) appear to be different based on whether L-alanine or D-
alanine is used, with a higher amount of the epimer produced in the D-alanine reaction (Figures 
5.3 and 5.4). Although this is not exactly surprising as chiral molecules such as hamigeran G (40) 
are known to influence the reaction by creating a prochiral surface in the intermediate resulting 
in a preferred configuration. What is unusual is that during isolation, the nitrogenous hamigerans 
and there epimers were isolated in near even amounts. This suggests a much more controlled 
reaction environment but further testing may be needed to confirm this relationship and to draw 
any strong conclusions.   
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Figure 5.3. 1H NMR spectrum of hamigeran D (33) and epimer (69) from L-alanine reaction. 
 
Figure 5.4. 1H NMR spectrum of hamigeran D (33) and epimer (69) from D-alanine reaction. 
 
5.4 Reaction of Hamigeran B (30) and Glycine 
So far, no nitrogenous analogues based on hamigeran B (30) had been isolated, despite it being a 
diketone like hamigeran G (40). This could possibly due to the isolation process excluding them 
either as they are only present in the sponge in very low abundances or that there is no reactivity 
between amino acids and hamigeran B (30). To test the latter reasoning, the glycine reaction was 
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repeated replacing hamigeran G (40) with hamigeran B (30). No colour change was observed, 
even after extending the reaction overnight with analysis of the 1H NMR spectra confirming that 
no reaction had taken place.  
5.5 Reaction of Hamigeran B (30) and Ammonium 
At this time a step back was needed to be taken. It was hypothesized that if hamigeran B (30) 
would not react with the amino acids, it potentially would not react with an ammonium source to 
form an imine either. A reaction of ammonium formate with hamigeran B (30) was undertaken. 
Unlike the reaction of ammonium formate and hamigeran G (40), which had an instant colour 
change, no change was initially observed. However, after several hours the reaction mixture 
changed from bright yellow to a dull peach colour. Leaving it for 24 hours resulted in a final 
colour change leaving it as an orange solution. 1H NMR data suggested a reaction had taken 
place, likely the formation of imine (70). The spectra was further complicated with the presence 
of hamigeran B (30) and an unidentified compound, possibly a diimine. Further analysis of this 
mixture was hindered by the reactivity of the imine compound (70) reverting back to hamigeran 
B (30). This reversion seemed to favour the ketone compared to the imine as for hamigeran G 
(40). This could also explain the lack of reactivity seen between hamigeran B (30) and glycine. 
The difference in ring size of the B rings, hamigeran B (30) and G (40) seem to strongly affect 
their reactivity with ammonium and amino reactants. It may also provide the explanation as to 
why no nitrogenous hamigeran B analogues have been isolated.  
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5.7 Reaction of Hamigeran G (40) and L-phenylalanine  
With the reactions of L-alanine, glycine and D-alanine working so well, a reaction with a bulky 
amino acid was tested to see if it altered the reaction outcome. The reaction of L-phenylalanine 
with hamigeran G (40) proceeded in the same manner as with the other amino acids with the 
loss of the bright yellow colour. 1H NMR analysis revealed both hamigeran N (52) and its C-18 
epimer (53) (Figure 5.5).  The relative amounts of each compound could not be obtained from 
the CH-18 resonance due to the overlap and was instead identified from the CH-4 peak, with 
hamigeran N (52) present in a 5:1 ratio with the epimer (53) (Figure 5.6).  
  
     
52     53 
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Figure 5.5. 1H NMR spectrum of CH-18 proton of hamigeran N (52) and epi Q (53). 
 
Figure 5. 6. 1H NMR spectrum of CH-4 proton of hamigeran N (52) and epi Q (53). 
 
5.8 Analysis of the reactions 
It was unfortunate that the imine (66) did not spontaneously form hamigeran S (65). The 
forming of the double hemiaminal structure should drive the reaction forward, presuming it 
would be able to get that far in the series of equilibria. One possible explanation is the phenol 
may require a form of activation for it to be able to attack the imine. Natividad’s synthesis of the 
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dithiocin imine and dioxocin imine compounds also performed reactions that produced trimers, 
including the trithiazine (71) and trioxazine (72) compounds. These were produced from reflux 
of  
1-hydroxy-2-naphthaldehyde or thiosalicylaldehyde with ammonium acetate, acetic acid and 
toluene. The key differences in this reaction were acid and solvent. Ethanol, being a protic 
solvent, may possibly be having a strong solvating interaction with the phenol, reducing its ability 
to attack.51 Ethanol was selected as the solvent of choice as it provided excellence yields in the 
formation of the dithiocin imine and dioxocin imine compounds.  The sterics of dimerization of 
hamigeran G (40) may have been a factor as without enzymatic control, the reaction kinetics 
would be slowed. The reaction should be repeated changing the conditions and solvent to find a 
possible route to dimerization, unfortunately this is beyond the scope of this master’s research.  
    
71     72 
The mechanism for the formation of the nitrogenous hamigerans from the reaction of amino 
acids and hamigeran G (40) proposed by Singh required the use of a hydride acceptor during 
decarboxylation of the amino acid. This could be explained in a biological system with NADH+ 
but this does not make sense in a “test tube” reaction. Overall, the reaction loses H2O, CO2, 2H
+ 
and 2e- through oxidation. An alternative to this is loss of 2H2O and CO, with the oxidation 
occurring with the CO. A proposed mechanism for a loss of CO is shown in Scheme 5.1, where 
the amino acid attacks forming the initial imine. An electron cascade starting from the phenol 
results in the loss of the carboxylic acid as CO and H2O. An electrocyclic ring closing could then 
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occur to restore the aromaticity of the A ring resulting in the nitrogenous hamigeran product. 
Testing for presence of CO during this reaction could help in verification of this mechanism. 
Methylation of the carboxylic acid of the amino acid would also verify this mechanism, as this 
would not halt the reaction. Instead it would produce MeOH in exchange for one of the H2O 
molecules. If however the reaction mechanism is producing CO2 then the methylation of the 
amino acid will prevent the decarboxylation from occurring, potentially limiting the reaction to 
the imine product. This hypothesis would very interesting to test but due to time limits this will 
have to wait. 
Scheme 5.1. Revised proposed formation of nitrogenous hamigerans. 
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Chapter 6: Biological Activity of the Hamigerans 
 
The preliminary results for testing against HL-60 cell lines of the seven new hamigerans are 
summarized in Table 6.1, provided by the School of Biological Science at VUW. Interestingly, 
hamigeran G (40), which was retested to use as a comparison, did not exhibit the same levels of 
cytotoxicity as it normally features (Table 6.2). Regardless of this, all the analogs of the known 
hamigerans (37, 60, 62, 63, 64) showed a comparable level of biological activity to their 
counterparts. This is consistent with previously tested hamigerans, with debromination, addition 
of bromine or methylation of an acid group not altering the IC50 significantly.  
Hamigerans R (61) and S (65) were an anomaly being over an order of magnitude weaker than 
the other hamigerans. It is thought from the isolation of hamigeran Q (57) and the two epimers 
(58, 59), that the nitrogenous hamigerans come from a mixed biogenesis with bacteria reacting 
an amino acid with hamigeran G (40) to reduce its potency. This same logic could be applied to 
hamigeran R (61) and S (65), with the bacteria releasing an ammonium source instead of an 
amino acid, resulting in the formation of less cytotoxic products.  
Retesting of biological activity is needed for all the new hamigerans before any more conclusions 
are drawn. 
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Table 6.1. Hamigeran IC50 Values [HL-60, n = 3 replicates, except for (40) and (64) n=2]. 
Compound Mean IC50 ± SEM 
(µM) 
Hamigeran G (40) 18.0 ± 0.1 
Debromohamigeran B (37) 43.0 ± 5.7 
Debromohamigeran I (60) 19.6 ± 0.8 
Debromohamigeran J (62) 19.4 ± 1.5 
Hamigeran L 12-O-Methyl Ester (63) 15.9 ± 1.1 
4-Bromohamigeran A (64) 19.6 ± 1.1 
Hamigeran R (61) >100 
Hamigeran S (65) >100 
 
Table 6.2. Hamigeran IC50 Values (HL-60, n = 3 replicates). 
Compound Mean IC50 ± SEM 
(µM) 
Compound Mean IC50 ± SEM 
(µM) 
Hamigeran A (28) 16.0 ± 4.5 4-Bromohamigeran K (47) 5.6 ± 0.4 
Debromohamigeran A (29) 12.5 ± 3.4 10-epi-Hamigeran K (48) 28.5 ± 1.6 
Hamigeran B (30) 3.4 ± 0.4 Hamigeran L (49) 78.3 ± 0.5 
Hamigeran D (33) 6.1 ± 0.3 Hamigeran L 11-O-Methyl Ester (50) 21.1 ± 3. 
Hamigeran F (38) 4.9 ± 1.2 Hamigeran M (51) 6.9 ± 0.4 
Hamigeran F Rearrangement (39) 7.4 ± 1.9 Hamigeran N (52) 19.5 ± 0.6 
Hamigeran G (40) 2.5 ± 0.2 18-epi-Hamigeran N (53) 14.1 ± 0.4 
Hamigeran H (42) 16.5 ± 1.4 Hamigeran O (54) 14.7 ± 0.4 
Hamigeran I (43) 37.2 ± 1.4 Hamigeran P (55) 21.3 ± 0.7 
Hamigeran J (44) 48.2 ± 1.2 18-epi-Hamigeran P (56) 11.6 ± 0.2 
Hamigeran K (46) 13.7 ± 0.6 Hamigeran Q (57) 33.3 ± 0.6 
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Chapter 7: Concluding remarks 
 
Further studies on the Hamigera tarangaensis have continued to be rewarding with isolation of 
seven new hamigeran congeners. The semi-purified fractions first generated by Singh proved to 
be rich in new compounds. Separation of the 80% Me2CO/H2O fraction resulted in the isolation 
of four analogues to previously known hamigerans (37, 62, 63, 64). The 60% and 100% 
Me2CO/H2O fractions, which had not been previously investigated, proved to a good source of 
novel compounds leading to the isolation of hamigeran R (61) and S (65) along with the isolation 
of another analogue of a known hamigeran (60). 
There were over a dozen fractions that contained resonances in 1H NMR indicative of a 
hamigeran which did not match any of the known compounds. Unfortunately it is not always 
possible to follow up each one. This was sometimes due to low mass or lack of purity after 
fractionation. Often the most promising fractions were focused in on, with time considerations 
restricting further investigation into others. From the 100% Me2CO fractions in which 
hamigeran S (65) was isolated, there appeared to be indication of hamigerans that were even 
more non-polar than hamigeran S (65), which could suggest a trimer, along with fractions 
containing potentially interesting steroids and a compound that appeared to change colour 
depending on whether it was exposed to fluorescent or natural light. There is possibly dozens of 
other hamigerans compounds that the sponge produces that we are yet to isolate, though that in 
is self does not warrant reinvestigation. Replication would be more and more likely with any 
subsequent study and the biological activity of the hamigerans has indicated it to be not 
exceptional regardless of their wonderful structures. 
The surprising success of the reactions resulted in the semi-synthesis of the two new congeners, 
the glycine hamigeran (68) and the epimer (69) to hamigeran D and two intermediates, 
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hamigeran G imine (66) and hamigeran B imine (70). The two congeners are both likely present 
in the sponge and are yet to be isolated. The two imines however, if generated in the sponge 
would not last long before H2O would displace the imine to reform the ketones or go on to 
form other compounds. Overall with the isolation efforts and the semi-synthesis the gaps in the 
table of hamigerans have started to be filled in, while also creating new ones (Table 7.4 and Table 
7.5).  
The sponge’s key compounds, in terms of the biological activity that has been tested, are 
hamigeran B (30) and hamigeran G (40), two nearly identical compounds, differing by a 
methylene unit. Hamigeran G (40) itself appears to be the origin of most of the nitrogenous 
hamigerans. This may be the sponge’s way to diversify its chemical defences as a way of 
lessening predation or possibly the response of bacteria living in the sponge in a way to deal with 
the toxicity of hamigeran G (40), transforming it to a less potent analogue. If this is the case it 
would be unknown how the bacteria would combat hamigeran B (30). The addition of 
hamigeran R (61) and S (65) has only added to the oddity of this family of compounds.  
It would be beneficial to repeat the hamigeran G imine (66) reaction under different conditions 
such as changing the solvent to toluene or trying alteration to the pH to see if the synthesis of 
hamigeran S (65) can be achieved. Other beneficial reactions would be attempting to attach an 
amino acid to hamigeran G (40) which has an acidic or basic functionality. Such functionality 
would likely hinder the reaction, or cause further reactions. This may be why no such 
nitrogenous hamigeran of this type has been isolated so far. The reaction by Nicolaou of 
debromohamigeran B (37) to debromohamigeran E (36) with H2O2 and NaOH could be tried on 
hamigeran G imine (66) which could result in the formation of hamigeran R (61) or hamigeran L 
(49) depending on whether the imine would react with H2O2 or not. More pressing is the 
reaction of a methylated amino acid with hamigeran G (40), evidence of CO generation would be 
very intriguing.   
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Table 7.4. Total isolated hamigerans (new in blue). 
 
 
 
 
 
 
 
 
 
Table 7.4. Isolated and semi-synthesised nitrogen containing hamigerans  
(new in blue, synthesised in red). 
oxazole amino hamigerans Amino acid hamigerans 18-epi-amino acid hamigerans 
hamigeran M (51) glycine hamigeran (68)  
 hamigeran D (33) 18-epi-Hamigeran D (69) 
 hamigeran N (52) 18-epi-hamigeran N (53) 
 hamigeran O (54)  
 hamigeran P (55) 18-epi-hamigeran P (56) 
 hamigeran Q (57) 18-epi-hamigeran Q (58) 
 19-epi-hamigeran Q (59)  
   
Debrominated Ammonia hamigerans 4-Brominated 
 hamigeran R (61)  
 hamigeran S (65)  
 hamigeran G imine (66)   
 hamigeran B imine (70)  
 
 
 Debrominated Hamigerans 4-Brominated 
ha
m
ig
er
an
e 
debromohamigeran A (29) hamigeran A (28) 4-bromohamigeran (64) 
debromohamigeran J (62) hamigeran J (44)  
debromohamigeran E (36) hamigeran E (35)  
debromohamigeran B (37) hamigeran B (30) 4-bromohamigeran B (31) 
 hamigeran K (46) 4-bromohamigeran K (47) 
 10 epi-hamigeran K (48)  
is
oh
am
ig
er
an
e 
hamigeran H (42)   
 hamigeran F (38)  
 hamigeran C (32)  
debromohamigeran I (60) hamigeran I (43)  
 hamigeran G (40)  
 hamigeran L (49)  
 hamigeran L 11-O-methyl ester (50)  
  hamigeran L 12-O-methyl ester (63)  
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Chapter 8: Experimental 
 
8.1  General experimental methods 
 
NMR spectra were obtained using a Varian DirectDrive spectrometer equipped with a triple 
resonance HCN cryogenic probe, operating at 25 K at frequencies of 600 MHz, 150 MHz and 
60 MHz for 1H, 13C, 15N nuclei respectively. Chemical shifts δ (ppm) were referenced to the 
residual solvent peak.54 All spectra were run in CDCl3 or DMSO-d6. 
1H NMR quantifications of 
samples were performed with an internal CH3NO2 standard using acquisition parameters as 
described by West.55 HRESIMS results were obtained from an Agilent 6530 Q-TOF mass 
spectrometer equipped with an Agilent 1260 HPLC for solvent delivery utilising a JetStream™ 
electrospray ionisation source in positive and negative ion modes. 
Optical rotations were measured using Rudolph Autopol II polarimeter in the solvent CH2Cl2. 
UV/vis spectra were recorded on the Agilent 8453 diode Array Spectrometer in MeOH. IR 
spectra were recoreded using the Bruker Platinum ATR, deposited as a thin film by evaporation 
of a drop of CH2Cl2. TLC plates were developed in 5% MeOH/CH2Cl2 and visualised under a 
UV lamp source (λ = 254 nm), then analysed by dipping in a solution of 5% KOH 
(conc.)/MeOH followed up by heating. Reversed-phase column chromatography was achieved 
using Supelco Diaion HP20, HP20SS or Tosohass Amberchrom poly(styrene-divinylbenzene) 
(PSDVB) chromatographic resin. 
Two separate HPLC systems were used for fine separation, firstly Agilent Technologies 1260 
Infinity HPLC equipped with a quaternary pump, a thermostatted column compartment and 
diode array detector (DAD). Secondly using a Rainin Dynamax SD-200 solvent delivery system 
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with 25 mL Pump heads. A C-18 semi-preparative column was used for all HPLC seperation. 
UV/vis detection for HPLC runs was obtained with a Varian Prostar 335 photodiode array 
detector. Solvents used for reversed-phase column chromatography are of HPLC or analytical 
grade quality. All other solvents were purified by distillation before use and filtered. Solvent 
mixtures are reported as % vol/vol unless otherwise stated. 
Sponge material used was fractions generated by Singh. The sponges were originally collected 
from various locations around northland, New Zealand by the Marine Natural Products Group, 
VUW, and stored ar -20 °C until required. Identification of the sponge used a subsample 
immersed in concentrated HNO3 until all organic matter had dissolved leaving the spicules 
which were analysed under optical and scanning electron microscopy (SEM). This was then 
compared to literature. Purified compounds were submitted to the school of Biological Sciences, 
VUW for biological testing. 
8.2  Isolation of Compounds from Hamigera tarangaensis  
The work by Singh during his thesis generated several fractions that did not get past the first 
stage of purification. Work up to the f-j and k-o fractionation of the samples of sponges was 
done by Singh. LH20 work and later was done as part of this thesis. Of the Fractions a-e, d was 
investigated extensively by Singh and later on by Dattelbaum leading to the isolation of 
hamigeran F (38) to 18-epi-hamigeran Q (59).  
8.3  Hamigerans S (65) and other Hamigerans 
Frozen Hamigera tarangaensis (PTN2_71J, 514.6 g), collected from Matai Bay Pinnacle, Cape 
Karikari, New Zealand, was cut into small pieces and extracted with MeOH (2 x 1.7 L). The 
second and first extracts were cyclic loaded (to 13.6 L of H2O and MeOH) on a column packed 
with 1 L HP20, pre-equilibrated in MeOH. The column was eluted with 3L portions of i) H2O, ii 
20% Me2CO/H2O (fraction f), iii) 40% Me2CO/H2O (fraction g) iv) 60% Me2CO/H2O (fraction 
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h) v) 80% Me2CO/H2O (fraction i) and vi) Me2CO (fraction j). The fractions f-j were diluted 
threefold with H2O, backloaded on to 200ml HP20 pre-equilibrated in MeOH, and eluted with 
600ml MeOH or Me2CO. 
A portion of fraction i (c. 2.5 g) was loaded onto a LH20 column pre-equilibrated in 50% 
MeOH/CH2Cl2 over three columns, each column taking several hours to elute, often run over 
night with fractions automatically collected every fifteen minutes. All the fractions eluted from 
the column where combined four parts, fats (green), A (brown), B (orange), C (yellow). Portions 
of B were put though HPLC, (gradient, 40 min 80%, ramp to 95% over five min, MeOH/0.2M 
Formic (aq)) over a series of runs and recombined generating a total of 16 fractions, D-S. This 
lead to the isolation of several previously identified hamigerans including debromohamigeran A 
(29) (fraction H, tR 16.8 min , 24.8 mg), hamigeran G (40) (fraction J, tR 20.4 min, 34.1 mg) 
hamigeran A (28) (fraction L, tR 28.8  min , 8 mg) hamigeran B (30) (fraction O, tR 43.4 min , 7.9 
mg) dibromohamigeran B (31) (fraction Q, tR 48.5 min , 20.7 mg). Further purification with the 
same conditions with the fraction E generated of seven fractions, T-Z and lead to the isolation 
of hamigeran F (38) (6.8 min, 0.1 mg) in fraction W and the new compound, debromohamigeran 
J (61) (tR 7.3 min, 1.1 mg) in fraction X. Fraction F was also submitted to further HPLC, 
(gradient, 25 min 60% ramp to 100% over five min, MeCN/0.2M Formic (aq)) generated 12 
fractions, AA-AM from which fraction AD gave hamigeran L 12-O-methyl ester (63) (tR 12.4 
min, 2.7 mg) and fractions AI afforded debromohamigeran B (37) (tR 21.4 min, 1.3 mg). Work 
up fraction N with two isocratic HPLC (85%, 80%, MeOH) runs lead to the isolation of 4-
bromohamigeran A (64) (tR 33.8 min, 1.8 mg). 
The fraction j (3.3 g) was also subjected to a LH20 column, under the same conditions as the 
previous LH20 column. The eluted fractions were separated into 5 parts, fats (green), AR 
(brown), AS (red), AT (orange), AU (yellow). HPLC (isocratic, 100% MeOH) was used to 
separate AS into nine fractions, AV-BD, with AX taken up for further purification on HPLC 
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(isocratic, 95% MeOH/H2O). This lead to the isolation of Hamigeran S (65) from one of the 
three fractions, BG (tR 12.8 min, 14.0 mg). 
8.4  Hamigerans R (61) and Debromohamigeran I (60) 
Frozen Hamigera tarangaensis (PTN2_79F, 202.2 g), collected from Taheke reef, Cavalli Island, 
New Zealand, was cut into small pieces and extracted with MeOH (2 x 1 L). The second and 
first extracts were cyclic loaded (to 8 L of H2O and MeOH) on a column packed with 1 L HP20, 
pre-equilibrated in MeOH. The column was eluted with 3 L portions of i) H2O, ii 20% 
Me2CO/H2O (fraction k), iii) 40% Me2CO/H2O (fraction l) iv) 60% Me2CO/H2O (fraction m) 
v) 80% Me2CO/H2O (fraction n) and vi) Me2CO (fraction o). The fractions k-o were diluted 
threefold with H2O, backloaded on to 200ml HP20 pre-equilibrated in MeOH, and eluted with 
600ml MeOH or Me2CO. 
The entirety of fraction m (c. 0.55 g) was loaded onto a LH20 column pre-equilibrated in 50% 
MeOH/CH2Cl2. The column produced 95 fractions. Which were pooled into four parts, fats 
(green), A (brown), B (orange), C (yellow). Part C (77.0 mg) was subjected to HPLC, (gradient 
80% - 95% MeOH/0.2M Formic (aq)) resulting in nine fractions D-L with the fractions G and H 
having debromohamigeran I (60) (tR 10.0 min, 1.3 mg) and hamigeran R (61) (tR 10.9 min, 2.4 
mg), respectively. 
8.5  Reactions of the hamigerans  
All reactions excluding the initial NMR tube reaction of hamigeran G (40) and ammonia(aq) were 
in absolute ethanol. All ammonium containing reactions performed in sample vials at room 
temperature. All amino acid containing reactions performed in round bottle flasks under reflux 
in a 10:1 ratio of amino acid to hamigeran. 
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Synthesis of hamigeran G imine (66)  
Hamigeran G (5 mg, 0.0132 mmol) was dissolved in EtOH (10 ml). Ammonium formate (0.8 
mg, 0.0132 mmol) was added, reacting instantly. The reaction was concentrated under reduced 
pressure to yield a bright red film which contained 66. The reaction was repeated with 2 mg 
(0.0264 mmol), 4 mg (0.0528 mmol) and 8 mg (0.1048 mmol) of ammonium formate till 
maximum conversion appeared to be obtained. 
Synthesis of hamigeran D (33) and epimer (69) from reaction with hamigeran G (40) and  
L-alanine 
Hamigeran G (5 mg, 0.0132 mmol) was dissolved in EtOH (10 ml). L-Alanine (12 mg, 0.1322 
mmol) was added and the reaction stirred under reflux for 2 hours. The reaction was filtered 
through HP20ss with Me2CO and the filtrate was concentrated under reduced pressure to yield a 
pale yellow film. This was purified with HPLC (isocratic, 85% MeOH/H2O) resulting in 4 
fractions, the third fraction containing both compounds 33 and 69 (tR 6.5 min, 2.3 mg). 
Synthesis of glycine hamigeran (68) from reaction with Hamigeran G (40) and glycine 
Hamigeran G (2.5 mg, 0.0066 mmol) was dissolved in EtOH (10 ml). Glycine (5 mg, 0.0662 
mmol) was added and the reaction stirred under reflux for 2 hours. The reaction was filtered 
through HP20ss with Me2CO and the filtrate was concentrated under reduced pressure to yield a 
pale yellow film. This was purified with HPLC (isocratic, 85% MeOH/H2O) resulting in 6 
fractions, the forth fraction containing both compounds 68 (tR 9.3 min). 
Synthesis of Hamigeran D (33) and epimer (69) from reaction with hamigeran G (40) and  
D-alanine 
Hamigeran G (3 mg, 0.0079 mmol) was dissolved in EtOH (10 ml). L-Alanine (7 mg, 0.0793 
mmol) was added and the reaction stirred under reflux for 2 hours. The reaction was filtered 
through HP20ss with Me2CO and the filtrate was concentrated under reduced pressure to yield a 
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pale yellow film. This was purified with HPLC (isocratic, 85% MeOH/H2O) resulting in 4 
fractions, the third fraction containing both compounds 33 and 69 (tR 6.6 min, 1.5 mg). 
Attempted synthesis of hamigeran B glycine compound 
Hamigeran B (2.5 mg, 0.0069 mmol) was dissolved in EtOH (10 ml). Glycine (5 mg, 0.0687 
mmol) was added and the reaction stirred under reflux for 2 hours. No colour change occurred, 
so reflux was extended 12 hours. The reaction was filtered through HP20ss with Me2CO and the 
filtrate was concentrated under reduced pressure to yield starting material hamigeran B (30). 
Synthesis of hamigeran B imine (70)  
Hamigeran B (5 mg, 0.0069 mmol) was dissolved in EtOH (10 ml). Ammonium formate  
(4.4 mg, 0.0687 mmol) was added, slight colour change noted. Reaction stirred at room 
temperature for 5 hours, equilibrated another 24 hours. The reaction was concentrated under 
reduced pressure to yield a dull orange film which contained 70.  
Synthesis of Hamigeran N (52) and epimer (53) from hamigeran G (40) and  
L-phenylalanine  
Hamigeran G (1.5 mg, 0.0039 mmol) was dissolved in EtOH (10 ml). L-Alanine (7 mg, 0.0396 
mmol) was added and the reaction stirred under reflux for 2 hours. The reaction was filtered 
through HP20ss with Me2CO and the filtrate was concentrated under reduced pressure to yield a 
pale yellow film. This was purified with HPLC (isocratic, 85% MeOH/H2O) resulting in 8 
fractions, the eighth fraction containing both compounds 52 and 53 (tR 19.2 min). 
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Hamigeran A (28). Yellow film; IR νmax 3500 (O-H), 2956 (C-H aromatic), 2850 (C-H), 1738 
(C=O ester), 1634 (C=O ketone), 1173 (C-O); All other data previously described. 
Debromohamigeran A (29). Pale yellow film; IR νmax 3500 (O-H), 2956 (C-H aromatic), 2870 
(C-H), 1736 (C=O ester), 1637 (C=O ketone), 1231 (C-O); All other data previously described. 
Hamigeran B (30). Bright yellow film; IR νmax 2957 (C-H aromatic), 2871 (C-H), 1725 (C=O 
ketone), 1634 (C=O ketone); All other data previously described. 
Debromohamigeran B (37). Bright yellow film; [𝛼] 25
𝐷
 -80.5° (c 0.42, CH2Cl2); UV (MeOH) λmax 
262 nm (ε 4300), 311 nm (ε 4300), 356 nm (ε 2200); NMR data see Table 3.2; HRESIMS 
[M+H]+, observed m/z 287.1645, calculated 286.1572 for C18H22O3H, Δ = +1.08 ppm. 
Debromohamigeran I (60). Pale yellow film; [𝛼] 25
𝐷
 -50.4° (c 0.635, CH2Cl2); UV (MeOH) λmax 
216 nm (ε 28000), 278 nm (ε 6900); NMR data see Table 3.3; HRESIMS [M+H]+, observed m/z 
319.1902, calculated 318.1829 for C19H26O4H, Δ = −0.6  ppm.  
Debromohamigeran J (62). Pale yellow film; [𝛼] 25
𝐷
 -104.4° (c 0.58, CH2Cl2); UV (MeOH) λmax 
288 nm (ε 2400); NMR data see Table 3.4; HRESIMS [M+NH4]
+, observed m/z 364.2118, 
calculated 346.179 for C20H26O5NH4, Δ = +2.8 ppm.  
Hamigeran L-11-O-methyl ester (50). Colourless film; IR νmax 2956 (C-H aromatic), 2870 (C-
H), 1721 (C=O ester), 16710 (C=O acid), 1241 and 1192 (C-O ester stretch); All other data 
previously described. 
Hamigeran L-12-O-methyl ester (63). Colourless film; [𝛼] 25
𝐷
 +89.4° (c 0.89, CH2Cl2); UV 
(MeOH) λmax 286 nm (ε 2400), 485 nm (ε 570); NMR data see Table 3.5; HRESIMS [M+H]
+, 
observed m/z 427.1114, calculated 426.1039for C20H27O5
79BrH, Δ =−0.77 ppm.  
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4-Bromohamigeran A (64). Pale yellow film; [𝛼] 25
𝐷
 -65° (c 0.88, CH2Cl2); UV (MeOH) λmax 229 
nm (ε 18000), 281 nm (ε 9700), 356 nm (ε 4800); NMR data see Table 3.7; HRESIMS [M+H]+, 
observed m/z 503.0063, calculated 501.9987 for C20H24O5
79Br2H, Δ = −0.62 ppm.  
Hamigeran R (61). pale yellow film; [𝛼] 25
𝐷
 -45.6° (c 1.205, CH2Cl2); UV (MeOH) λmax 219 nm (ε 
32000), 309 nm (ε 2300), 339 nm (ε 2900); NMR data see Table 4.2; HRESIMS [M+NH4]
+, 
observed m/z 411.128, calculated 393.0942 for C19H24NO3
79BrNH4, Δ = +0.52 ppm; Negative 
ion mode HRESIMS [M−H]−, observed m/z 392.0867, calculated 393.0942 for C19H23NO3
79Br, 
Δ = −1.83 ppm: IR νmax 3222 (O-H), 2956 (C-H), 2223 (C≡N), 1704 (C=O)  cm
-1.  
Hamigeran S (65). colourless film; [𝛼] 25
𝐷
 +33.4° (c 6.385, CH2Cl2); UV (MeOH) λmax 291 nm (ε 
4200), 485 nm (ε 1900); NMR data see Table 4.3; HRESIMS [M+H]+, observed m/z 738.1788, 
calculated 737.1703 for C38H45NO4
79Br2H, Δ = -1.64 ppm, [M+2H2O+Na]
+, observed m/z 
798.1812, calculated 737.1703 for C38H45NO4
79Br22H2ONa, Δ = +1.22 ppm: IR νmax 3300 (N-H), 
2956 (C-H), 1728  (C=O)  cm-1.  
Imine Hamigeran (66). Bright red film; NMR data see Table 5.1.  
Glycine Hamigeran (68). Pale yellow film; NMR data see Table 5.2; HRESIMS [M+H]+, 
observed m/z 390.1061, calculated 389.0987 for C20H24O5
79BrNO2H, Δ = −0.77 ppm. 
Hamigeran D epimer (69). Pale yellow film; 1H NMR (600MHz, CDCl3) δ CH-18 6.32  
(1H, d), 5.07 (1H, d), other peaks not identified; HRESIMS [M+H]+, observed m/z 406.1154, 
calculated 403.1151 for C21H26O5
79BrNO2H, Δ = 1.12 ppm. 
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A Debromohamigeran B NMR Spectra 
 
1H NMR spectrum of debromohamigeran B (37) in CDCl3 (600 MHz). 
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13C NMR spectrum of debromohamigeran B (37) in CDCl3 (150 MHz). 
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COSY NMR spectrum of debromohamigeran B (37) in CDCl3 (600 MHz). 
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HSQC NMR spectrum of debromohamigeran B (37) in CDCl3 (600 MHz). 
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HMBC NMR spectrum of debromohamigeran B (37) in CDCl3 (600 MHz). 
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2D NOESY NMR spectrum of debromohamigeran B (37) in CDCl3 (600 MHz). 
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B Debromohamigeran I NMR Spectra 
 
1H NMR spectrum of debromohamigeran I (60) in CDCl3 (600 MHz). 
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13C NMR spectrum of debromohamigeran I (60) in CDCl3 (150 MHz). 
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COSY NMR spectrum of debromohamigeran I (60) in CDCl3 (600 MHz). 
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HSQC NMR spectrum of debromohamigeran I (60) in CDCl3 (600 MHz). 
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HMBC NMR spectrum of debromohamigeran I (60) in CDCl3 (600 MHz). 
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2D NOESY NMR spectrum of debromohamigeran I (60) in CDCl3 (600 MHz). 
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C Debromohamigeran J NMR Spectra 
 
1H NMR spectrum of debromohamigeran J (62) in CDCl3 (600 MHz). 
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13C NMR spectrum of debromohamigeran J (62) in CDCl3 (150 MHz). 
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COSY NMR spectrum of debromohamigeran J (62) in CDCl3 (600 MHz). 
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HSQC NMR spectrum of debromohamigeran J (62) in CDCl3 (600 MHz). 
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HMBC NMR spectrum of debromohamigeran J (62) in CDCl3 (600 MHz). 
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2D NOSEY NMR spectrum of debromohamigeran J (62) in CDCl3 (600 MHz). 
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D Hamigeran L -O- methyl ester NMR Spectra 
 
1H NMR spectrum of hamigeran L -O- methyl ester (63) in CDCl3 (600 MHz). 
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13C NMR spectrum of hamigeran L -O- methyl ester (63) in CDCl3 (150 MHz). 
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COSY NMR spectrum of hamigeran L -O- methyl ester (63) in CDCl3 (600 MHz). 
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HSQC NMR spectrum of hamigeran L -O- methyl ester (63) in CDCl3 (600 MHz). 
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HMBC NMR spectrum of hamigeran L -O- methyl ester (63) in CDCl3 (600 MHz). 
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2D NOESY NMR spectrum of hamigeran L -O- methyl ester (63) in CDCl3 (600 MHz). 
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E 4-Bromohamigeran A NMR Spectra 
 
1H NMR spectrum of 4-bromohamigeran A (64) in CDCl3 (600 MHz). 
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13C NMR spectrum of 4-bromohamigeran A (64) in CDCl3 (150 MHz). 
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COSY NMR spectrum of 4-bromohamigeran A (64) in CDCl3 (600 MHz). 
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HSQC NMR spectrum of 4-bromohamigeran A (64) in CDCl3 (600 MHz). 
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HMBC NMR spectrum of 4-bromohamigeran A (64) in CDCl3 (600 MHz). 
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2D NOESY NMR spectrum of 4-bromohamigeran A (64) in CDCl3 (600 MHz). 
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F Hamigeran R NMR Spectra 
 
1H NMR spectrum of hamigeran R (61) in CDCl3 (600 MHz). 
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13C NMR spectrum of hamigeran R (61) in CDCl3 (150 MHz). 
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COSY NMR spectrum of hamigeran R (61) in CDCl3 (600 MHz). 
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HMBC NMR spectrum of hamigeran R (61) in CDCl3 (600 MHz). 
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HMBC NMR spectrum of hamigeran R (61) in CDCl3 (600 MHz). 
136 
 
 
2D NOESY NMR spectrum of hamigeran R (61) in CDCl3 (600 MHz). 
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G Hamigeran S NMR Spectra 
 
1H NMR spectrum of hamigeran S (65) in CDCl3 (600 MHz). 
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13C NMR spectrum of hamigeran S (65) in CDCl3 (150 MHz). 
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COSY NMR spectrum of hamigeran S (65) in CDCl3 (600 MHz). 
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HSQC NMR spectrum of hamigeran S (65) in CDCl3 (600 MHz). 
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HMBC NMR spectrum of hamigeran S (65) in CDCl3 (600 MHz). 
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1H H2O experiment NMR spectrum of hamigeran S (65) in CDCl3 (600 MHz). 
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13C H2O/D2O NMR spectrum of hamigeran S (65) in CDCl3 (150 MHz). 
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1H NMR spectrum of hamigeran S (65) in DMSO (600 MHz). 
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13C NMR spectrum of hamigeran S (65) in DMSO (150 MHz). 
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COSY NMR spectrum of hamigeran S (65) in DMSO (600 MHz). 
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HSQC NMR spectrum of hamigeran S (65) in DMSO (600 MHz). 
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HMBC NMR spectrum of hamigeran S (65) in DMSO (600 MHz). 
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2D NOESY NMR spectrum of hamigeran S (65) in DMSO (600 MHz). 
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15N decoupled HMBC NMR spectrum of hamigeran S (65) in DMSO (600 MHz). 
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1D ROSY irradiating 2.39 ppm NMR spectrum of hamigeran S (65) in DMSO (600 MHz). 
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1D ROSY irradiating 5.46 ppm NMR spectrum of hamigeran S (65) in DMSO (600 MHz). 
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H Imine from Hamigeran G reaction NMR Spectra 
 
1H NMR spectrum of imine (66) from hamigeran G reaction in CDCl3 (600 MHz). 
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13C NMR spectrum of imine (66) from hamigeran G reaction in CDCl3 (600 MHz). 
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COSY NMR spectrum of imine (66) from hamigeran G reaction in CDCl3 (600 MHz). 
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HSQC NMR spectrum of imine (66) from hamigeran G reaction in CDCl3 (600 MHz). 
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HMBC NMR spectrum of imine (66) from hamigeran G reaction in CDCl3 (600 MHz). 
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I Hamigeran D and Epimer from L-alanine Reaction NMR Spectra 
 
1H NMR spectrum of hamigeran D (33) and epimer (69) in CDCl3 (600 MHz). 
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1H NMR spectrum of Close up of C-18 protons hamigeran D (33) and epimer (69) in CDCl3 (600 MHz). 
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J Hamigeran D and Epimer from D-alanine Reaction NMR Spectra 
 
1H NMR spectrum of hamigeran D (33) and epimer (69) in CDCl3 (600 MHz). 
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1H NMR spectrum of Close up of C-18 protons hamigeran D (33) and epimer (69) in CDCl3 (600 MHz). 
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K Glycine Hamigeran NMR Spectra 
 
1H NMR spectrum of Glycine hamigeran (68) in CDCl3 (600 MHz). 
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13C NMR spectrum of Glycine hamigeran (68) in CDCl3 (600 MHz). 
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COSY NMR spectrum of Glycine hamigeran (68) in CDCl3 (600 MHz). 
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HSQC NMR spectrum of Glycine hamigeran (68) in CDCl3 (600 MHz). 
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HMBC NMR spectrum of Glycine hamigeran (68) in CDCl3 (600 MHz). 
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2D NOESY NMR spectrum of Glycine hamigeran (68) in CDCl3 (600 MHz). 
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L Imine from hamigeran B reaction NMR Spectra 
 
1H NMR spectrum of imine (70) from hamigeran B reaction in CDCl3 (600 MHz). 
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M Hamigeran N and Epimer NMR Spectra 
 
1H NMR spectrum of hamigeran N (52) and epimer (53) in CDCl3 (600 MHz). 
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